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CHAPTER I 
Introduction 
Acoustic neuromas are intracranial benign tumors which usually occur in the 
internal auditory meatus of the skull. The tumor expands in the posterior 
cerebello-pontine angle, and involves major cranial nerves, cerebellar 
arteries and the brain stem. Acoustic neuromas arise from the eight cranial 
nerve. This nerve has an approximately 2 cm course between the brainstem 
and the inner ear. The origin of an acoustic neuroma is the Schwann cell of 
either the superior or inferior vestibular division of the eight cranial nerve. A 
more accurate term therefore would be "vestibular schwannoma", but the 
term "acoustic neuroma" has made its way into the literature and has 
generally prevailed. The tumor originates in the region of Scarpa's ganglion 
at the Schwann cell-glial junction (Sterkers et al, 1987). This junction of 
peripheral and central myelin is known as the "Obersteiner-Redlich" zone. 
The abundant number of cells in the ganglion are irregularly distributed, and 
are thought to give rise to the acoustic neuroma. While the neuroglial-
neurolemmal junction most often occurs in the vicinity of the vestibular 
ganglion of Scarpa, its localisation varies considerably. This variability has 
been argued to account for the variable site of origin of acoustic neuromas 
along the vestibular nerve. Degeneration of a benign acoustic neuroma into a 
malignant schwannoma has been reported by McLean et al (1990), but is 
exceedingly rare. 
Acoustic neuromas usually present with symptoms of audiovestibular impair-
ment, unilateral sensorineural hearing loss and tinnitus with or without imba-
lance. These tumors are mischievous in that about 5% of patients have 
normal hearing at the time of presentation. In addition some patients present 
atypically with for instance sudden hearing loss, Meniere-like symptoms, 
fullness in the ear or trigeminal neuralgia. If undiagnosed the acoustic 
neuroma grows medially in the direction of least resistance, and may eventu-
ally cause neurological symptoms and ultimately death by brainstem 
compression, and by mass effects within the skull. Vestibular schwannomas 
constitute the most common tumor of the posterior cranial fossa with an 
annual incidence of 1/100.000 of the population and accounts for 
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approximately 6% of all intracranial tumors. They occur in all races, and a 
female predilection has been noted, although not in a substantial degree. 
Acoustic tumors occur in two distinct clinical presentations. This thesis is 
about the sporadic unilateral tumor without any genetic transmission, which 
occurs mostly later in life. The unilateral tumors comprise some 95% of 
cases. The bilateral hereditary tumors occur in 5% of the patients. They 
often have neurofibromatosis type II and present often at a younger age. 
The neurofibromatoses I and II, as defined by the NIH Consensus 
Development Conference on Neurofibromatosis in 1987, are characterized by 
the presence of neurofibromas, and periferal and central nervous system 
tumors. Neurofibromatosis I was previously labeled "von Recklinghausen's 
disease" or "periferal neurofibromatosis", and neurofibromatosis II was 
labeled "central neurofibromatosis" (Recklinghausen, 1882). To avoid confu-
sion about the histological nomenclature a further distinction should be made 
between a neurofibroma and a schwannoma. The cutaneous manifestations of 
neurofibromatosis I, the more common disease with a prevalence of 
40/100.000, are neurofibromas. The central manifestations of 
neurofibromatosis II, with a prevalence of about 1/100.000, are 
schwannomas. Two genetically distinct forms of neurofibromatosis have been 
described. The genetic origin of neurofibromatosis I has been identified on 
chromosome 17 (Wallace et al, 1990), while the gene for neurofibromatosis 
II has been found on chromosome 22 (Rouleau et al, 1987). While virtually 
all patients with neurofibromatosis II eventually manifest bilateral acoustic 
neuromas, this tumor is rare in the neurofibromatosis type I (Hitselberger 
and Hughes, 1968). Because of the differences in symptoms, age of onset, 
number of central and periferal lesions, choices of therapy and postoperative 
management between the unilateral and the bilateral tumors this thesis is 
limited to the unilateral sporadic acoustic neuroma. 
History of acoustic neuromas: 
*** 1770-1840 *** The recognition decades *** 
The history of acoustic neuromas starts with sporadic reports of a tumor of 
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the cerebello-pontine angle. In 1777 the post mortem (acoustic) tumor case 
of Sandifort is described, with hardly any information regarding the clinical 
findings of the patient. Famous is the combination of a clinical report with 
an autopsy report of Sir Charles Bell (1774-1842), published in London in 
1830. Jean Cruveilhier (1791-1874) wrote another detailed report in 1842 
about a patient with an acoustic tumor. The first symptom was deafness, and 
the autopsy described a enlarged poms acousticus internus. At that time 
some diagnostic procedures were developed, but the lesions were still beyond 
any form of treatment (Hoogland 1984; House 1979). G.I. Stevens (1879) 
and Hermann Oppenheim (1890) reported additional cases during the 
Nineteenth Century. 
*** 1840-1860 *** The anesthesia decades *** 
The discovery of ether anesthesia opened up new possibilities for carefully 
planned procedures to correct various pathological lesions that had 
previously been documented at the autopsy table. Nevertheless brain surgery 
remained almost always fatal, because of the sepsis after penetrating the 
dura. 
*** 1860-1880 *** The asepsis decades *** 
After publications by Ignace Philip Semmelweiss (1818-1865) and Louis 
Pasteur (1822-1895) the surgeon Joseph Lister (1827-1912) recognised in 
1867 the connection between micro-organisms and infections. Simple 
procedures like washing hands became common, and the principle of 
antiseptic surgery was born. 
*** 1880-1890 *** The neurology decade *** 
Neurology was established in major centres as a medical speciality by 
Hermann Oppenheim (1858-1919), Josef Babinski (1857-1932) and many 
others. Neurologists now could recognize a patient with a brain tumor, 
knowing symptoms like papil oedema arising by increased intracranial 
pressure. Cerebellar symptoms like ataxia and dysmetria were described after 
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experimental studies. 
*** 1890-1900 *** The neurosurgery decade *** 
The first reports of succesfull removal of brain tumors were published, 
among many failures. Sir Charles Ballence successfully removed a tumor 
from the posterior fossa in 1894 but Harvey Cushing (1869-1939) later 
doubted that the tumor was an acoustic neuroma and thought that it was 
more likely to have been a meningeoma. He therefore attributed the first 
removal of an acoustic neuroma (or fibrosarcoma) in 1895 to a Scot, Thomas 
Annandale of Edinburgh. Sir Charles Ballance (1907) operated a patient in 
1892 by the suboccipital approach, and is probably one of the first to have 
removed an acoustic neuroma successfully. Postoperative the patient was 
alive and well, with only a facial palsy and facial anesthesia of the fifth 
nerve. 
*** 1900-1920 *** The posterior fossa surgery decades *** 
Symptoms of patients with a posterior fossa tumor were diagnosed because 
of the well described and known cerebellar symptoms. The term "cerebello-
pontine angle tumor" was introduced by Henneberg and Robert Koch (1843-
1910) in 1902. Neurosurgery was still often lethal in those days, with a 
mortality rate between 70% and 90% in Europe. F. Krause in 1903 reported 
on 84% operative mortality using the unilateral suboccipital approach. 
Cushing published in 1917 the results of his bilateral suboccipital exposure 
and partial tumor removal, and had to face extensive criticisms. Cushing 
used a bilateral suboccipital approach to the posterior fossa, which allowed 
not only a wide decompression but also the opportunity to explore both sides 
because it was not always possible to determine the exact location of the 
lesion preoperative^. New surgical procedures in the posterior fossa were 
proposed, like by Panse in 1904, with his translabyrinthine approach. Quix 
performed the first purely translabyrinthine craniotomy in 1911 in Utrecht. 
Walter Dandy favoured total removal of acoustic tumours via a unilateral 
suboccipital approach and performed his first such case in 1917, then only 
thirty-one years old. By 1925 he had accomplished total removal in 
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seventeen patients. 
*** 1920-1960 *** The life saving procedures decades *** 
The major aims of surgery shifted from symptom allevation and prolongation 
of life to an attempt to cure the patient. Diagnostic procedures were 
improved by X-rays showing the widening of the internal acoustic canal 
(Henschen 1895) and later the cerebral pneumo-encephalography (Dandy 
1919). Caloric testing procedures were used after publications by Barany 
(1906). The side of the tumor could be detected in an earlier stage. 
Refinement of surgical techniques, decreasing tumor size because of earlier 
detection, and antibiotics caused a decrease in operative mortality by 20 to 
40%. The peroperative occlusion of the anterior-inferior cerebellar artery 
was recognised as a major cause of operative fatality by Atkinson in 1949. 
Olivecrona was in 1940 the first to place great emphasis on anatomical facial 
nerve preservation. 
*** 1960-1970 *** The microscope decade *** 
Using the microscope was a great advance in cerebello pontine surgery. The 
otologists and neurosurgeons began to cooperate, and teams like Hitselberger 
and House (1966) published excellent results (House 1964, 1968). Many 
different approaches were introduced like the transcochlear and middle fossa 
approach, and later the transotic approach. It now was possible not only to 
save the patients life, but also the facial nerve function and sometimes also 
hearing. New audiometrie, vestibular and radiological procedures became 
reliable clinical methods of investigation. 
*** 1970-1980 *** The BERA and CT decade *** 
Brainstem evoked response audiometry (BERA) showed an high accuracy for 
acoustic neuroma, and became rapidly popular. It proved to be the most 
reliable audiometrie method for the detection of acoustic neuroma. The new 
polytomography technique was preferred for the initial examination of the 
temporal bone, rather than the plain X-rays of Stenver, Chamberlain-
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Towne, Schuller, and the lateral skull views. Later the computerized axial 
tomografy (CT) methods using intravenous dye solutions was able to detect 
all lesions over 2 cm. 
*** 1980-1990 *** The MRI decade *** 
Advanced computerised radiology with new generations of CT-scanners were 
introduced. Admission of oil and later air in the intrathecal space made it 
possible to accurately detect the small intrameatal tumors. Magnetic 
resonance imaging (MRI) is the newest form of producing pictures of 
acoustic tumors, and with the intravenous admission of Gadolinium® tumors 
of two ore three millimeter now are detected. MRI became the new gold 
standard in acoustic neuroma diagnosis. 
*** 1990-2000 *** The reflection decade *** 
The revolution in diagnostic procedures made it possible to detect a tumor in 
a very early stage. The evolution in surgical techniques now promises a low 
mortality and complication rate as well as saving of the facial nerve function, 
and sometimes hearing. The aims of the treatment of acoustic neuromas are 
revised. In case of a small tumor a "wait and see" policy sometimes is 
followed. It will be possible and necessary to know more about the natural 
history and growth rate of this tumor. Not only the surgical parameters are 
important, but also the quality of life after surgery should be investigated and 
optimalised. 
Acoustic neuroma nowadays: 
The diagnostic and surgical possiblities of our decade have developed 
rapidly. With the application of magnetic resonance imaging (MRI) the 
relative incidence of smaller acoustic neuromas has increased. Tumor size at 
the time of diagnosis is a reflection of diagnostic efficiency. The impact of 
the larger number of patients with a smaller tumor must be evaluated. The 
typical clinical presentation of the patients is changing (Selesnick et al, 
1993). In the posterior fossa surgery decades of 1900-1920 Cushing saw 
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many patients with advanced disease, and made a chronology of symptoms 
beginning with subtle complaints and ending with severe intracranial 
complications and death. He proposed the following sequential stages: 1. 
auditory and labyrinthine dysfunction; 2. occipitofrontal pain; 3. cerebellar 
ataxia; 4. involvement of adjacent cranial nerves; 5. evidence of increased 
intracranial pressure; 6. dysphagia and dysarthria; 7. brainstem compression 
with a decreased respiratory drive and death. In our decade we may find 
more and more patients in stage 1, and even in a new stage 0: patients with 
atypical complaints or without specific complaints known to be related to an 
acoustic neuroma. 
The increasing number of patients with sparse symptoms require a different 
kind of care. One of the first questions of these patients will be if it is 
necessary to undergo treatment for this small benign lesion. Since the 
growing rate of acoustic neuroma is uncertain (Laasonen et al, 1986), and 
some tumors may not grow and even sometimes seem to disappear (Redleaf 
et al, 1993), there is not yet a straightforward answer. The next question of 
the patient may be what kind of treatment is the right choice. This answer is 
even more difficult. Many centres published their surgical results (Welch et 
al, 1985; Shelton et al, 1989; Ebersold et al, 1992; Haid and Wigand, 1992; 
Thomsen et al, 1992; King et al, 1993; Chen and Fisch, 1993; Sterkers et al, 
1994), but all approaches have advantages as disadvantages as well. The 
ideal treatment of total removal with no risk of additional damage to 
surrounding structures has not been found yet. With respect to the 
postoperative quality of life of different approaches still little research has 
been done. One might wonder why still such large acoustic tumors are found 
despite of all the new diagnostic tools available nowadays. Is it because the 
patient presents with unclear symptoms, or is it the physician, who does not 
use the right diagnostic techniques, considering it to be an insignificant 
hearing loss? On the other hand, the diagnosis may be hard to find because 
of the large number of patients with very common complaints, also 
suggestive for an acoustic neuroma. Often it will turn out to be another more 
common disease, like otosclerosis, Morbus Meniere, sudden deafness or just 
presbyacusis. Should an acoustic neuroma at any time be included in the 
differential diagnosis? 
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In the present situation most of the centres who treat patients with an 
acoustic neuroma cannot offer all the approaches, and select for each patient 
the most favourable surgical procedure. In the past, several studies have 
been published comparing different approaches. This situation has lead to the 
conclusion that one or another method was the way to a better result, 
depending on the criteria used. Shea (1979) stated that the suboccipital route 
was the procedure of choice. DiTullio (1978) considered the suboccipital 
approach as the only adequate treatment for patients with medium or large 
lesions. Wiet (1986) stated that the translabyrinthine method had proven 
satisfactory for complete removal of acoustic tumors of all sizes. Tos and 
Thomsen (1982) concluded that their overall results were clearly in favour of 
the translabyrinthine approach. Mangham (1988) wrote that the choice 
between translabyrinthine and suboccipital approaches should reflect the 
surgeons strengths and weaknesses, since both procedures have simular 
complication rates. The choice of approach may thus be influenced also by 
the capabilities and experience of the surgeons. Gaining more experience 
with one of the approaches the surgeon will affect the results of the 
operation. In our modern decade of superb technical support, facial nerve 
monitoring and effective antibiotics it is possible to test abandonned 
procedures again. An example is the choice of a near-total and subtotal 
removal of the tumor. Kartush and Lundi (1992) gave a clear definition of 
the extent of removal. Sometimes non radical surgery is indicated, but total 
removal is advocated if possible. Jackler (1994) stated several conditions for 
non-radical surgery, as life-threating complications during surgery, in case of 
neurofibromatosis patients, or as a concession to cranial nerve preservation. 
Also the hearing status of the other ear is relevant. Remarkable in the theme 
of hearing conservation are the results of research by Offeciers et al (1992), 
where in some cases also the cochlear nerve was involved in the tumoral 
process. Does it matter that small remnants of tumor capsule or even tumor 
remain on the facial and cochlear nerve? Moffat and Hardy (1992) stated 
that, below a certain tumor volume at some sites, small aggregates of tumor 
may be of no clinical significance. The question remains, if it is a safe 
alternative to perform a less than total resection, because of the 
impredictable growth rate of acoustic neuroma remnants. 
In the Nijmegen University Hospital acoustic neuromas have been treated for 
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many years. 
There is a close and optimal cooperation between the surgeons of 
otolaryngology and neurosurgery in this hospital. The patient charts are 
carefully kept by otolaryngologists, neurologists and neurosurgeons and offer 
a complete history. 
Translabyrinthine operations are performed since the posterior fossa decades. 
In Nijmegen this was started by Dr. Ed Marres in 1973, who later on 
founded the Department of Otolaryngology of the Maastricht University 
Hospital. Since 1980 more than 100 patients have been operated in the 
Nijmegen University Hospital by the translabyrinthine/transotic approach by 
Dr. Cor Cremers. Performing this approach there was by its success a shift 
in technique from the translabyrinthine to a modified transotic procedure. 
The method used at this moment can best be described as a modified wide 
translabyrinthine approach with occlusion of the external meatal canal. The 
neurosurgeons on the other hand have used the suboccipital approach. 
Patients with all tumor sizes were operated, whereas the otolaryngologists 
used to operate on tumors up to 35 mm. The neurosurgeons prefered a near-
total or subtotal removal of the tumor in most cases. 
In this thesis the different approaches with respect to tumor sizes and patient 
data were compared within one centre. The period of the study is between 
1980 and 1992. In this period 164 patients have been operated on with an 
unilateral acoustic neuroma. The quality of life study includes also patients 
operated on in 1993. 
Aims of this thesis: 
Many questions are still unanswered while we meet rapidly changing 
opinions about the ideal diagnostic procedure and treatment of acoustic 
neuromas. A screening program for acoustic neuroma is not possible when 
no selection criteria are used. Scanning the whole population every year with 
Gadolinium® enhanced MRI-scans is not realistic. Robson et al (1993) 
concluded that MRI as a single screening procedure is a cost effective 
protocol in case of asymmetrical audiovestibular symptoms. In the selection 
of diagnostic procedures are besides knowledge of symptoms also 
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correlations between the several data of the patient helpfull. Do those 
correlations exist? The symptoms of very large tumors are often clear and 
everyone is quite certain not to miss this pathology. However with smaller 
tumors, in stage 1 or even "stage 0" of Cushing the selection may be very 
difficult. In chapter II we try to correlate tumor size, symptoms and patient 
age. 
The time necessary needed to reach the diagnosis depends on many factors. 
The first step in the diagnosis is the day that the patient visits the general 
practitioner with a complaint. The physician examines the patient, and finally 
decides to refer the patient to a specialist who should be able to diagnose an 
acoustic neuroma. This is step two, and also the specialist needs time for the 
diagnosis. It is worthwile finding out why it takes such a long time before 
patients with an acoustic neuroma are recognised. Is it the patient and the 
general practitioner, who cause a delay, or is it the specialist, or both? Are 
there special reasons for missing an acoustic neuroma, and can they be 
elimated? In chapter III we present the diagnostic delays for acoustic 
neuroma referred to and diagnosed in the Nijmegen University Hospital, and 
we present also the causes for some large delays. 
The translabyrinthine approach is used by mainly otolaryngologists for 
acoustic neuroma surgery, and several surgeons have tried to improve this 
technique. Returning problems are the limited space for the removal of the 
tumor, en the rise of postoperative leakage of cerebrospinal fluid. Enlarging 
the approach anteriorly in the direction of the cochlea resulted in the 
transotic approach, first proposed by Fisch. In the Nijmegen series we 
started in 1973 with the translabyrinthine approach, but afterwards a 
modification of the transotic approach was preferred. Effects of the alteration 
of technique, and of the increased experience with cerebello-pontine angle 
surgery are presented in chapter IV. 
The suboccipital approach has been the prevalent choice of the 
neurosurgeons in the Nijmegen University Hospital for all sizes of acoustic 
neuroma. This technique is closely related to the retrosigmoid approach. In 
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the view of the neurosurgeons it was often preferable to perform a subtotal 
removal in case of risk of neurological damage or causing facial nerve 
trauma. The results of surgery may be influenced by this choice. The 
outcome regarding the complications and facial nerve function should be 
equal or better compared with radical surgery. On the other side the residual 
tumor may cause problems. In chapter V the results of the suboccipital 
surgery for acoustic neuroma in the Nijmegen University Hospital are 
presented. 
Quality of life after surgery is a relatively new item in the literature. What 
will be the quality of life after acoustic neuroma surgery? This may depend 
on other factors than the surgical parameters of success. If the surgeon is 
satisfied, the patient may be not. Many people could be more interested in 
the chances of working again after surgery than in the House Brackmann 
classification of the facial nerve function. The patient's quality of life may 
depend on changes of hearing, tinnitus or vertigo. How do patients manage 
at home when they are dismissed from the hospital, and is help needed? Do 
patients think they can function in daily life as they did before the operation? 
Possibly the choice of the approach, the size of the tumor and previous 
operations affect these patient-derived results. In chapter VI we present the 
data of a questionnaire we have sent to our patients. 
Although a case report may seem of limited value, they do often carry a 
message which adds important information on a small special subject. In 
large series of patients some remarkable findings are met. One of the 
patients had a complete acoustic neuroma examination in 1979, and no 
definite proof for a tumor was found. After nine years the patient returned 
with a 4 cm acoustic neuroma. Having this data some considerations are 
made about follow up procedures, tumor growth rate and tumor doubling 
time. This case is presented in chapter Vila. 
Another patient was found to have a bilateral tumor in the cerebello-pontine 
angle. Although almost always the diagnosis is neurofibromatosis II another 
disease may nevertheless be present. In chapter VHb a rare double-sided 
tumor is presented. 
Not only acoustic neuroma are found in the cerebello-pontine angle. Patients 
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of all ages with symptoms as an unilateral sensorineural hearing always 
require a carenili examination. In chapter Vile a teenage patient is presented 
with such a hearing loss for several years, and a rare tumor in the cerebello­
pontine angle. The diagnostic procedures for children with unilateral 
sensorineural hearing loss or deafness are considered. 
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CHAPTER II 
Acoustic Neuroma: 
correlation among tumor size, symptoms, and patient age 
ABSTRACT 
Due to improved diagnostic techniques, acoustic neuromas more frequently 
are detected at an early stage. Subsequent treatment depends on such factors 
as expected tumor growth rate, tumor size, and patient age. The natural 
history of acoustic neuromas is still uncertain: 
This study was performed to examine possible correlations among tumor size, 
patient age, signs and symptoms, and duration of symptoms. The study 
included 164 patients with an acoustic neuroma who were treated at 
University Hospital Nijmegen, The Netherlands, over a period of 13 years. 
Comparisons are made between the findings of this study and the literature. 
No support was found for any of the correlations mentioned in other studies, 
and no relationships could be demonstrated between the parameters 
evaluated in this study. The authors therefore recommend that treatment 
policies be based only on well-established correlations. 
INTRODUCTION 
Diagnostic procedures to detect an acoustic neuroma have become much 
more sensitive since the introduction of brainstem evoked response 
audiometry, computed tomography (CT) scanning, and magnetic resonance 
imaging (MRI) which has further improved sensitivity and specificity. These 
diagnostic procedures are also less difficult on patients than the previously 
used air cisternography. The newer diagnostic techniques have sometimes led 
to the unexpected diagnosis of an acoustic neuroma in patients with only 
slight symptoms. These visualization techniques have also made it possible 
for physicians to follow the growth of an acoustic neuroma before deciding 
wether surgical intervention is necessary. It has recently been established that 
fairly small differences in the size of an acoustic neuroma can influence the 
occurence of surgical complications1. 
Since many acoustic neuromas now are followed using MRI, various 
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questions have arisen about the natural history of these tumors. The most 
important questions concern the relationship between tumor growth rate, 
tumor size, and patients age. In addition, little is known about the 
distribution in individual growth rates. To answer these questions, it is 
necessary to perform descriptive studies that focus on possible correlations 
between tumor size, signs and symptoms, and patient age. 
From 1980 through 1992, 164 patients underwent primary surgery for an 
acoustic neuroma at the University Hospital Nijmegen, The Netherlands. 
Using the diagnostic data recorded on these patients, the authors of this study 
examined correlations between tumor size, signs and symptoms, and patient 
age. Where possible, these findings were compared with those reported in a 
simular study that was performed in Copenhagen2. 
MATERIALS AND METHODS 
From 1980 through 1992, 258 operations for various types of space-
occupying lesions in the cerebello-pontine angle were conducted in the 
University Hospital Nijmegen. This study is based on the diagnostic data 
from the 164 patients who were operated on for an acoustic neuroma for the 
first time. In performing the surgeries, the suboccipital approach was used in 
106 patients, the translabyrinthine, transotic, or combined approach was used 
in 56 patients, and the middle fossa approach was used in 2 patients. 
Excluded from the study were 36 patients who underwent a second surgery 
for an acoustic neuroma, 54 patients who were operated on for other 
histological diagnosis (N=54), and 4 patients who were known to have 
central neurofibromatosis type I or II and a tumor in the cerebellopontine 
angle. 
Tumor size was determined by a neuroradiologist. The maximum diameter of 
the total tumor was recorded, including the intrameatal part. There was a 
good agreement between these values and those found during surgery. Data 
on patient sex, patient age at surgery, signs and symptoms, and duration of 
symptoms were collected form the medical files. The results of pure-tone 
audiometry and speech audiometry were also collected. In this way, it was 
possible to examine various correlations using linear regression lines between 
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tumor size, patient sex, patient age, separate symptoms, duration of 
symptoms, extend of hearing, and speech recognition. In the correlations, the 
number of patients (N), the correlation coefficient (r) and the Ρ value are 
reported. 
Unexplained bone conducting asymmetry in the pure tone audiogram was the 
most frequent reason for further otoneurological investigation. The maximum 
difference in perception for the frequencies 0.5, 1.0, 2.0 and 4.0 kHz were 
determined for the patients with a unilateral acoustic neuroma in order to 
establish the extend of asymmetry for at least one frequency. This approach 
gave a practical indication of the degree of asymmetry in the hearing loss. 
Certain levels of asymmetry may give rise to the suspicion of an acoustic 
neuroma. 
RESULTS 
The study group included 88 women and 76 men, 17 to 79 years of age, 
with a mean age of 49.2 years. The majority of patients were between 40 
and 60 years of age (table 1). 
In the literature, the mean age varied between 45 and 51 years, with a 
maximum range of 3 to 90 years2"4. The number of patients with an acoustic 
neuroma who were operated on for the first time at the University Hospital 
Nijmegen from 1980 through 1992 varied from 7 to 20 per year. The mean 
tumor size was 26.5 mm (SD±13.2 mm) with a range of 8 to 72 mm. As 
shown in Figure 1, the mean tumor size decreased gradually but significantly 
during the study period (N = 163, r=.279, P=.00034). 
The relationship between tumor size and patient age at surgery is presented 
in a scatter diagram (Fig. 2). No significant correlation was found between 
tumor size and patient age (N=164, r=.O054, P=.49), since large and small 
tumors occurred in both young and older patients. To compare the findings 
of this study with those of the Copenhagen study2, the tumors were classified 
into the same three groups according to tumor size (i.e. 1 to 25 mm, 26 to 
40 mm, and greater than 40 mm). 
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Table I: 
Patient age at the time an acoustic neuroma was diagnosed: comparison 
between the Copenhagen and Nijmegen series: 
Patient Age Nijmegen Copenhagen 
< 40 y 
40-60 y 
> 60y 
25% 
52% 
23% 
24% 
45% 
31% 
60 
50 
g 40 
Oí 
•S 30 
о 
E 
5 20 
10 
• a • • · • a • ш 
в ·••• 
0 12 24 36 48 60 72 84 96 108 120 132 144 156 
month of operation 
Figure 1: 
Mean tumor size (mm) of acoustic neuromas from 1980 to 1992. 
This series started on January 1980 (month 1) and ended in December 1992 
(month 156). 
N = 163 (without one tumor of 72mm). 
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Figure 2: 
Relation between age at surgery and tumor size (N = 164) 
Table II: 
Tumor size and patient age: comparison between the Nijmegen and 
Copenhagen series: 
1-25 mm 26-40 mm > 40 mm All tumors 
Series Nijmegen Copenhagen Nijmegen Copenhagen Nijmegen Copenhagen Nijmegen Copenhagen 
(N=87) (N=60) (N = 17) (N = 164) (N=300) 
<40y 18.4% 
(16) 
40-60y 57.5 
(50) 
> 60y 24.1% 
(21) 
12% 
49% 
39% 
33% 
(20) 
44% 
(26) 
23% 
(14) 
26% 
48% 
26% 
35.3% 
(6) 
47.1% 
(8) 
17.6% 
(3) 
31% 
38% 
31% 
25% 
(41) 
51.8% 
(85) 
14.0% 
(23) 
24% 
45% 
31% 
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Table III: 
Tumor size, patient sex, and patient age in the Nijmegen series (N = 164) 
Tumor size Male Female Mean patient SD 
age 
1-25 mm 
26-40 mm 
>40 mm 
Total 76 88 49.2y ±14.2 
41 
28 
7 
46 
32 
10 
50.1 y 
49.2y 
45.5y 
±11.8 
±16.3 
±16.1 
Table Г : 
Main or presenting symptom of an acoustic neuroma in the Nijmegen series and other 
studies': 
author 
year 
N = 
this series 
1994 
164 
Selesnick' 
1993 
126 
Thomsen2 
1990 
300 
Ellis6 
1974 
214 
Ojemann7 
1972 
46 
hearing loss 
tinnitus 
vertigo/unsteadiness 
facial paraesthesia 
headaches 
sudden deafness 
73 
13 
7 
1 
0 
3 
67 
36 
16 
3 
* 
* 
75 
7 
8 
1 
* 
7 
71 
14 
8 
1 
12 
* 
73 
2 
11 
2 
9 
* 
' Certain symptoms were not mentioned in some studies. 
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The number of patients in each group is shown in Table II. The majority of 
tumors were found to occur in patients between 40 and 60 years of age. For 
each tumor size, the mean age and the male:female ratio were also determi­
ned (Table III). As tumor size increased, there was a nonsignificant decrease 
in mean age, from 50.1 to 45.5 years per year. A slightly higher proportion 
of women had a tumor (malerfemale rate of 1:1.16). 
Symptoms of an acoustic neuroma were divided into the presenting (main) 
symptom and all other symptoms in the history up to the time of surgery 
(Table Г ). The results reported in several other studies were included for 
comparison 2 · 5" 7. The presenting symptom in the majority of cases was 
unilateral hearing loss. Less frequent presenting symptoms included tinnitus, 
vertigo, and facial paresthesia. Figure 3 shows an overview of the percentage 
of patients with various signs and symptoms per tumor size at the first 
otological consultation. Small tumors in particular were associated with 
hearing loss and tinnitus, while vertigo and otalgia were infrequent symp­
toms. Large tumors were associated with headaches, facial paresthesia, and 
ataxia, while eye symptoms and dysarthria were less frequent. These findings 
agreed with those reported in the literature11. 
When all the signs and symptoms were analyzed together, their incidence 
changed and other symptoms gained more importance (Table V) 5 · 8 1 0 . 
Various symptoms were not always mentioned, including otalgia, sudden 
deafness, epilepsy, ataxia, nausea and vomiting, and dysarthria. In some 
studies vertigo was recorded as a symptom, while in others it was subclassi-
fied into, for example, true vertigo, unsteadiness and dizziness. This made 
comparison of the incidence impossible. Tumor size and the duration of the 
first symptom up to the diagnosis are presented in a scatter diagram in figure 
4. The symptoms of small and large tumors were of both short and long 
duration. Therefore, there was no relationship at all between, for example, a 
long history of a symptom and a large tumor diameter. 
Preoperative pure-tone audiometry results were available for 158 of the 164 
patients. For the remaining 6 patients the audiograms could not be traced. 
The mean hearing loss at the frequencies 0.5,1.0, and 2.0 kHz (Fletcher 
index) is shown in Figure 5. 
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HL TIN OTALG VISUS DYSARTR HEADACH VERTIGO SENSIB ATAXIA 
Figuur 3: 
Percentage of different symptoms of acustic neuromas related to tumor size 
(N = 164) 
The three tumor size caisses are 1-25 mm (white bars), 26-40 mm (grey 
bars) and larger than 40 mm (black bars). 
(HL=hearing loss, TIN=tinnitus, VISUS=eye problems like diplopia, 
DYSARTR=dysarthria, HEADACH=headaches, SENSIB = facial paresthae-
sia 
There was no significant correlation between the level of hearing loss and the 
size of the tumor (N = 158, r=.068, P = .40). Small tumors could be 
associated with considerable hearing loss, and large tumors with a slight 
hearing loss - all the combinations occured frequently. When these data were 
analyzed per tumor size (Table VI), the majority of patients (51%) had a 
hearing loss between 41 and 80 dB, irrespective of tumor size. The 
difference in hearing thresholds between the affected ear and the normal ear 
was also assessed. The largest bone conducting difference was noted per 
frequency, between 0.5 and 4.0 kHz. As shown in Table VII, the mean 
asymmetry for one frequency was 57.7 dB (SD±23.1 dB). 
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Table V: 
All signs and symptoms of an acoustic neuroma in the Nijmegen series and 
other studies*: 
author 
year 
N = 
this series 
1994 
164 
Selesnick5 
1993 
126 
Pfaltz' 
1991 
93 
Wiegand' 
1989 
541 
Mathew10 
1978 
206 
hearing loss 
tinnitus 
vertigo/unsteadiness/dizziness 
(combined) 
otalgia/otic pressure sensation 
sudden deafness 
headaches 
epilepsy 
ataxia/tremor 
eye symptoms 
VII paresis 
racial paresthesia 
nausea/vomiting 
dysarthria 
93 
57 
29 
12 
3 
24 
4 
33 
7 
5 
22 
3 
3 
85 
56 
67 
* 
* 
19 
* 
* 
3 
10 
20 
* 
* 
83 
70 
50 
* 
* 
25 
* 
* 
* 
10 
20 
* 
* 
86 
57 
61 
28 
* 
36 
* 
* 
22 
* 
29 
* 
* 
97 
66 
69 
+ 
4 
29 
* 
8 
15 
22 
33 
11 
* 
'Certain symptoms were not mentioned in some studies. 
The patients in this study usually had asymmetrical hearing loss; in 95% of 
cases, there was at least a 20-dB difference for one of the frequencies 
between 0.5 and 4.0 kHz.A speech audiogram was available for 122 of the 
164 patients. Maximum speech recognition scores were determined (Table 
VIII). In figure 6, speech recognition values and tumor size are presented in 
a scatter diagram. In accordance with the pure-tone audiogram, tumor size 
did not significantly influence speech recognition (N = 122, r=.134, P = .14). 
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Figure 4: 
Time interval between first symptoms and first consulation with otologist or 
neurosurgeon, related to tumor size (N=164) 
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Figure 5: 
Degree of sensorineural hearing loss (mean value at 0.5, 1 and 2 kHz) 
related to tumor size (N = 158) 
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Table VI: 
Tumor size and hearing loss in the pure tone audiogram at 0.5, 1.0 and 2.0 
kHz (Fletcher index). Comparison between the Copenhagen and Nijmegen 
series. 
tumor 
size < 26mm 26-40mm > 40mm all sizes 
Fletcher 
Index 
Nijmegen Copenhagen Nijmegen Copenhagen Nijmegen 
(N=87) (N = 97) (N=60) (N=85) (N = 17) 
Copenhagen 
(N=118) 
Nijmegen 
(=164) 
Copenhagen 
(N = 300) 
0-20 dB 
21-40 dB 
41-80 dB 
> 80 dB 
7% 
6 
29% 
(25) 
53% 
(46) 
11% 
(10) 
5% 
13% 
59% 
23% 
3% 
(2) 
22% 
(13) 
50% 
(30) 
15% 
(9) 
3% 
21% 
49% 
27% 
18% 
(3) 
24% 
(4) 
40% 
C7) 
18% 
(3) 
1% 
14% 
43% 
51% 
7% 
(11) 
26% 
(42) 
51% 
(83) 
13% 
(22) 
3 % 
16% 
4 6 % 
35% 
In the Nijmegen senes the results were unknown for 6 patients with a tumor size 26 to 40 mm. 
Table VII: 
The maximum difference in hearing loss for at least one of the frequencies 
0.5-4 kHz related to tumor size in the Nijmegen series. 
tumor size maximum difference SD 
1-25 mm 
26-40 mm 
>40 mm 
57,7 dB 
57,1 dB 
57,3 dB 
± 2 2 , 5 dB 
± 2 0 , 9 dB 
± 3 1 , 4 dB 
total 57,5 dB ± 2 3 , 1 dB 
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Table VIII: 
Phoneme score related to tumor size in the Nijmegen series: 
maximum speech recognition Tumor size Tumor size Tumor size 
< 26 mm 26-40 mm > 40 mm 
N=75 N=31 N=16 
70-100% 37 (50%) 17 (55%) 9 (56%) 
40-69% 25 (33%) 9 (29%) 5 (31%) 
< 4 0 % 13 (17%) 5 (16%) 2 (13%) 
DISCUSSION: 
The fact that there was no clear relationship between tumor size, signs and 
symptoms, and the level of hearing loss means that even with optimal 
diagnostic facilities, it is difficult to ensure that only small acoustic neuromas 
are detected. In reviewing the relationships between tumor size, level of 
hearing loss, and patient age, the authors of this study found it striking that 
the expected correlations did not exist. It would not have been surprising to 
find a relationship between tumor size and patient age or between tumor size 
and the level of hearing loss. 
An acoustic neuroma can occur at almost any age, but most tumors are 
found in patients of 40 to 60 years of age. In the present series, 75% of the 
patients were older than 40 years. In younger patients, the symptoms may be 
caused by central neurofibromatosis type II, which cannot always be 
recognized immediately. The average age of the patients at surgery was 
simular in all series2·5"10. 
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Figure 6: 
Phoneme score related to tumor size (N = 122) 
60 70 80 
The size of the tumors operated on at the University Hospital Nijmegen 
decreased gradually over the time period of the study (Fig. 1). The 
significant gradual decrease in mean tumor size per year, from 34 mm to 22 
mm, is probably due to earlier consultation with a physician, improved 
diagnostic techniques, and increased awareness of the consultants. In 
particular, MRI has facilitated the early detection of small tumors. 
Other authors4,5 also have mentioned a decrease in tumor size against time. 
However, the opposite was reported in the Copenhagen study2, which is 
representive of the whole of Denmark. The distribution of patients over the 
three age groups was very simular to that in the Copenhagen series. One 
striking difference was the number of patients with a tumor larger than 40 
mm: 118 patients (33%) in the Copenhagen series versus 17 patients (10%) 
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in the Nijmegen series. In view of the decrease in the number of large 
tumors found at various centres throughout the world, it may be appropriate 
to interprete the Copenhagen data cautiously, particularly with regard to the 
existence of correlations, because these correlations may be specific to the 
Danish population. External factors that influence the size of the tumors 
referred to a centre may include, for example, the referral pattern in that 
particular region and the expertise of the surgeon. 
An acoustic neuroma can occur at almost any age, and the tumor growth rate 
can vary greatly from individual to individual12. Little is known about the 
average growth rate and the distribution in the growth rates of acoustic 
neuroma. Whether these tumors grow more slowly in older patients also is 
uncertain. If the growth rate remains fairly constant, larger tumors generally 
should be found in elderly patients. No larger tumors were found in the 
elderly patients in the present study. Various growth rates appear to be 
possible at all ages, and it seems likely that varying growth rates can occur 
in a single patient. Table III shows that the average age of patients with a 
large tumor decreased gradually, although nonsignificantly, against time. 
However, this study found no correlation between tumor size and patient age 
(Fig. 2). 
It is possible that the growth rate varies, depending on whether the tumor 
has an isolated nongenetically determined etiology or an hereditary etiology, 
such as central neurofibromatosis type I or II. In light of recent genetic study 
results13, it has become reasonable to assume that a larger proportion of 
isolated cases of acoustic neuroma can be attributed to a chromosomal defect 
than would be expected on the basis of clinical symptoms or family studies. 
Future genetic studies may provide information that will help predict the 
expected growth rate of an acoustic neuroma. 
The symptoms of an acoustic neuroma vary, and in a retrospective review it 
is not always possible to distinguish clearly between the presenting symptom 
and all other symptoms. The presenting symptom is usually unilateral 
deafness - but not in all cases. In addition, the percentage of patients with 
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impaired hearing as their main symptom was found to decrease tumor as 
tumor size increased (Fig. 3). Therefore, tumor size appeared to influence 
the average complaint pattern. Classifying the symptoms of an acoustic 
neuroma into an audiovestibular stage, a trigeminal stage, or a brainstem 
stage is too absolute11. It would be better to speak in terms of a gradual shift 
in symptoms (Fig. 3). In the present study, no correlation was found 
between tumor size and the duration of symptoms (Fig. 4). In fact, some of 
the patients with very short-term symptoms had tumors that were mainly 
restricted to the intrameatal site. In contrast, the Copenhagen study12 
reported a significant relationship between tumor size and symptoms duration 
(P<.05). 
Wiegand and Fickel3 surveyed members of the American Acoustic Neuroma 
Association. Therefore, their study subjects were recruited using a procedure 
that was different from that employed in other studies (i.e., subjects were 
members of a patient association as opposed to patients operated on by the 
authors of the study). 
The incidence of hearing loss in the comparison studies (67% to 75 %)2,5"7 
was very simular to that found in the present series. The distribution in the 
other studies was higher for tinnitus (2% to 36%) and vertigo (7% to 16%). 
Facial paresthesia was only observed in 1% to 3% of patients, while sudden 
deafness and headaches were not always mentioned. Some symptoms were 
mentioned infrequently in the literature. For instance, ataxia occurred in 
33% of the patients in this series, but in only 8% of the patients in the study 
by Mathew, et al10. Symptoms such as sudden deafness occurred in only 3% 
to 4% of patients; however, in one study14, sudden deafness was listed as the 
presented symptom for small rumors in 19% of patients. If each of the 
possible symptoms of an acoustic neuroma were considered an indication for 
MRI, these tumors could be diagnosed much earlier. However, it is 
questionable wether the cost-benefit ratio would remain acceptable in view of 
the number of negative diagnoses. 
Unilateral hearing loss is the most frequent symptom of an acoustic neuroma, 
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but no correlation was found between tumor size and the level of hearing 
loss. Deafness was found in patients with tumors of all sizes, but relatively 
good hearing also could be present on the affected side. Figure 5 shows that 
all combinations of tumor size and hearing loss are possible. The findings of 
this study disagreed with those in the Copenhagen study2, which reported a 
relationship between tumor size and hearing loss for large rumors (P<.001). 
t 
The authors of the present study did find asymmetry in the hearing loss of 
the pure tone audiogram of at least 20 dB (average 57.7 dB). Asymmetrical 
hearing loss without any other symptoms is a strong indication for further 
otoneurological tests to look for an acoustic neuroma, even though a small 
proportion of patients with such a tumor will have a normal pure-tone 
audiogram. These findings agree with those reported in a study performed in 
Seattle15. The authors of the Seattle study recommended that if the average 
threshold difference at 1 to 8 kHz was 20 dB or greater, MRI should be 
performed on the suspicion of an acoustic neuroma. Brainstem evoked 
response audiometry should suffice in patients with an average threshold 
difference of less than 20 dB. 
CONCLUSION: 
Expected correlations among tumor size, symptoms, and patient age could 
not be demonstrated. Questions regarding tumor growth rate and the 
distribution in growth rates remain unanswered. It is not possible to say 
wether there is a relationship between the moment that a tumor starts to 
develop and the age of a patient; symptoms do not give any reliable indicati-
on. Since the authors of the present study could not demonstrate any of the 
correlations formerly assumed to exist, it would seem appropriate not to base 
the answers to any remaining questions about variation in tumor growth rate 
and the age of the patient on simular provisional assumptions. This would 
obviously have consequences on otoneurological diagnosis and would 
necessitate repeated cost-benefit analyses. Tumor growth rate is still 
unknown and therefore remains a problem in designing the treatment plan for 
a patient with an acoustic neuroma. 
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CHAPTER III 
Delays in the diagnosis of acoustic neuromas 
ABSTRACT 
From the medical files of 164 consecutive patients who underwent surgical 
treatment for a unilateral acoustic neuroma between 1980 and 1992, we 
collected data on the delay until the diagnosis was made. A distinction was 
made between the patient's and general practitioner's delay (delay 1) and the 
delay after the specialist's first visit untili the radiological diagnosis (delay 
2). The average delay was 35.7 months (SD 62.2) for delay 1 and 15.2 
months (SD 36.3) for delay 2. Specialist's delay (otolaryngologist or 
neurologist) was divided into a delay of a maximum of 12 months (134 
patients) and a longer delay (30 patients). In 27 out of the 30 patients, no 
specific tests had been performed and in the remaining three, the test results 
were inconclusive. Reasons for not conducting further tests included familial 
hearing impairment, Meniere's disease, otosclerosis and alcoholism. In cases 
where the specialist had not made the diagnosis within one year, it took an 
average of six months extra to make the diagnosis of an acoustic neuroma, 
usually with a fairly short patient delay. The specialist's delay remained 
constant in the period of investigation, with only in the last 2 year the 
possibility of MRI-scanning. In view of the increasing accessibility of MRI it 
is now recommended if possible to perform MRI in all patients with symptoms 
suspicious of an acoustic neuroma. 
INTRODUCTION 
Making a diagnosis will unavoidably take time. In some cases it will take 
longer than others. For instance, making the diagnosis of an acoustic 
neuroma can be difficult. The most common initial symptoms include 
unilateral deafness and tinnitus. In the majority of cases, there will be an 
alternative explanation for these symptoms, which is why a patient's delay 
and a doctor's delay can arise. If an acoustic neuroma is suspected, 
performing the necessary specific tests can also lead to delay, owing to a 
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waiting interval, limited accessibility and limited capacity of the testing 
facilities. In the literature, authors have seldom mentioned the time it took to 
make the diagnosis. Exceptions were the reports by Thomsen [1] and 
Traquina [2], in which these delays were mentioned for the two series of 
patients. 
This study was performed to investigate the various forms of delay which 
occurred in a series of patients who were operated on at the University 
Hospital Nijmegen between 1980 and 1992. Over the course of time, 
diagnostic imaging techniques have changed and improved. During the whole 
study period ABR examination and CT-scanning were available. In the initial 
period of the study around 1980, dilation of the internal acoustic meatus was 
examined radiologically mostly using Stenver's view. When the successive 
generations of CT scanners became available, firstly using oil and later air in 
the intrathecal sac in order to give contrast to the porous internal acoustic 
canal, this was the examination method of choice. In recent years, MRI has 
become the gold standard; tumors can be detected with a diameter of only a 
few millimetres. The average diagnosis time can be expected to decrease. 
MATERIALS AND METHODS 
In the period from 1980 to 1992, 164 patients underwent surgical treatment 
for a unilateral acoustic neuroma at the University Hospital Nijmegen. The 
patient's medical files were reviewed to obtain data on the time it took to 
arrive at the final diagnosis. In the Netherlands, patients with any type of 
symptoms or complaints are first seen by their general practitioner (GP). The 
GP decides whether the patient should be referred to a specialist (otolaryngo-
logist or neurologist) on the grounds of his or her symptoms. The period 
until the patients saw the specialist was called delay 1 in this study (patient's 
+ GP's delay). Some patients in the Netherlands, depending on their health 
insurance, can also go directly to a specialist without having to see their GP 
first. 
The patient is then examined by a specialist and sooner or later he will make 
the diagnosis of an acoustic neuroma, and he will sent the patient to a 
surgeon. This is referred to as delay 2 (specialist delay). The date on which 
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an acoustic neuroma was diagnosed radiologically was taken as the date of 
diagnosis. CT scanning first became available at our hospital in 1978; MRI 
became available in 1991 but initially, accessibility was extremely limited 
quantitatively. In only a minority of the patients in 1991 and 1992 a MRI 
scan was made. Delay is expressed in months in this study. 
RESULTS 
The average delay was 35.7 months (SD 62.2, between 0 and 468 months) 
for delay 1 and 15.2 months (SD 36.3, between 0 and 242 months) for delay 
2. The time necessary to make the diagnosis remained fairly constant over 
the 13-year study period (Figure 1), and no significant shift in the delay was 
found (N = 164, r=-0.038, p>0.40). The average diameter of the tumors 
gradually decreased from 33 mm in 1980 until 22 mm in 1992 (N = 164, r=-
0.279 , p<0.000 34) (Figure 2). In a group of 30 patients out of the original 
164, delay 2 was more than 12 months. We investigated the reasons for this. 
In 27 of them, no specific tests had been performed for pathology in the 
cerebello-pontine angle despite the fact that the symptoms were indicative of 
this. The complaints comprised asymmetrical perceptive hearing loss of at 
least 20 dB (N=28), vertigo and tinnitus (N=18), otalgia (N=4), ataxia 
(N=2) and headaches (N = 1). In three patients, the X-rays of the os 
petrosum (Stenver's view) were normal (N=2 in 1980) or the ECOG/BER 
test was normal (N = 1 in 1989). Reasons why no further tests had been 
carried out were mentioned in some of the patients' files. These included 
familial hearing impairment, Meniere's disease, otosclerosis and alcoholism. 
The diagnosis was made at a later date because of deterioration of the 
complaints or new symptoms (Table 1). The ultimate duration (delay 1 + 2 ) 
until the radiological diagnosis was made, was an average of 51.2 months 
(SD 74.1, between 0 and 505 months). In the 134 patients in whom the 
specialist's delay was shorter than 12 months, the total delay was an average 
of 39.1 months (SD 61.6), whereas in the 30 patients in whom the specia-
list's delay was longer than 12 months, it was 97.6 months (SD 98.9). Delay 
1 (patient + GP) was longer than 12 months (average 50.6 months, SD 
57.6) in 9 out of the 30 patients and less than 12 months in the remaining 
21. Table 2 shows the length of delay 1 + 2 per tumor size. Although the 
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differences were not significant owing to the large standard deviation, there 
was a visible trend that as the tumor diameter increased, delay 1 + 2 also 
increased from 67.4 months to 90.5 months. There was no correlation 
between delay 2 (specialist's delay) and the tumor size (Figure 3). In almost 
all cases the first (general) specialist who was referred to also finally made 
the diagnosis, and sent the patient to the surgeon. In the period of investiga­
tion CT-scanning was constantly available. There was no influence found on 
the delay from the MRI scan. This technique was only (limited) available in 
the last two years, and in this period only in a minority of patients a MRI 
scan could be made. 
19Θ0 | 1981 | 19Θ2 | 1983 | 1984 | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 
year of operation 
Figure 1: 
Specialist delay between 1980 and 1992 
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Table 1: 
Reason for further investigation 
Reason for further investigation no. of patients 
detonation of hearing impairment 
ataxia 
headache 
otalgia 
detoriation of vertigo 
walking problems 
trigeminal signs 
11 
7 
6 
3 
3 
3 
3 
ou 
50 
40 
JO 
20 
10 
η 
. 
-
-
1 1 1 1 1 1 1 1 1 1 1 1 
1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 
year of operation 
Figure 2: 
Mean tumor size and standard deviation per year 
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Table 2: 
Diagnostic delay and tumor size: Delay 1 is the patient's and general 
practioner's delay; delay 2 is the specialist's delay. Delay 1 + 2 is the time 
until an acoustic neuroma was diagnosed. 
tumor size/delay number of patients delay 1 (months) delay 2 (months) delay 1 +2 (months) 
1-25 mm 
> 40 mm 
87 
26-40 mm 60 
17 
27.2 
Sd 49.3 
46.1 
Sd 76.6 
44.5 
Sd60.2 
16.1 
Sd36.1 
9.1 
Sd 19.7 
32.4 
Sd 65.4 
43.2 
Sd 67.4 
54.6 
Sd 76.9 
76.8 
Sd90.5 
80 
60 
E 
E 
α> 
-У 4 0 
о 
E 
I · • • • S I 
20 
I • · • • •• · 
6 12 18 24 30 36 42 48 54 >60 
delay after the first consultation (months) 
Figure 3: 
Tumor size and specialist delay 
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DISCUSSION 
Delay is a sensitive issue in medical practice because of possible reproach 
and liability. It would be rash to speak in terms of a reprehensible medical 
error. "Duration" is a more neutral word. However, it is not our intention to 
pass judgement about various types of delay. Nevertheless it was interesting 
to examine in practice how much time elapsed before the diagnosis of an 
acoustic neuroma was made and to distinguish between various reasons for 
delay. 
Nowadays the diagnosis is made at a much earlier stage. In the past, 
symptoms of gross neurological impairment were generally necessary to give 
rise to the suspicion of cerebello-pontine angle pathology. Thanks to 
audiometry and particularly ABR examination, diagnosing retrocochlear 
pathology became much more efficient in the nineteen seventies. Revolutio-
nary developments in radiodiagnostics have led to MRI replacing CT 
scanning as the gold standard. The average tumor size decreased considera-
bly in our patient series owing to these improvements (Figure 2), which is in 
agreement with reports on other series [3]. 
Little attention has been paid to the time involved in present-day diagnosis, 
but this is becoming steadily more topical in legal proceedings. In the 
literature, this subject has been all but ignored. Thomsen & Tos [1] referred 
to a period of one year after referral as a situation with no diagnostic delay. 
They considered a longer duration to represent delay. After reviewing their 
series, they found "delay" in 233 out of the 300 patients (78%) seen between 
1976 and 1985. In the present Dutch study, the specialist had made the 
diagnosis within one year after referral in 134 out of the 164 patients (82%). 
The total duration (delay 1 + 2) from the presenting symptom until 
radiological diagnosis, was generally much longer. In this study, delay 1 + 
2 was longer than one year in 70% of the patients, thus the diagnosis was 
made within one year in only 30% of the patients. Traquina et al. [2] found 
a similar delay (delay 1 + 2) of more than one year after the presenting 
symptom in 19 out of the 26 patients (76%) seen from 1980 to 1987. The 
total duration until diagnosis in their study was 51 months, which is in close 
agreement with the 51.2 months in our study. The total average duration in 
the study by Thomsen & Tos [1] was 85 months. Levine et al. [3] mentioned 
the duration of symptoms (29 months) but not the delay until diagnosis. 
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Selesnick et al. [4] distinguished only between different delays per symptom. 
The average duration of, for example, hearing loss, tinnitus and vertigo 
symptoms prior to diagnosis was between 41 and 47 months. It is noteworthy 
that in the Nijmegen series, no correlation was found between the specialist's 
delay and tumor size (figure 3). One explanation for this is the slow growth 
rate typical of an acoustic neuroma. Earlier, no correlation was reported 
between the level of hearing impairment, the age of the patient and the tumor 
diameter [5]. 
It is not only the small tumors that go undetected by the specialist. Long 
delay does not necessarily lead to an exceptionally large tumor. In this 
series, we observed only a trend that the larger the tumor, the longer the 
diagnostic delay. Remarkable is the relatively small delay caused by the 
specialist of the tumors between 25 en 40 mm. 
Combinations of symptoms which mask the presence of an acoustic neuroma 
have been described occasionally. Clemis [6] mentioned that otosclerosis was 
the masking symptom in 15 of his own patients; he also found similar reports 
in the literature. It is always worth considering whether a long-term 
symptom such as hearing loss, which ultimately signifies the presence of 
cerebello-pontine angle pathology, could have had a different cause at an 
earlier stage. We know that in recent years, an acoustic neuroma of a few 
millimetres diameter can be detected with MRI and that this sometimes 
occurs in patients who have been suffering from asymmetrical hearing loss 
for e.g. 15 years. Therefore it is justified to doubt whether there is always 
really a causal relationship between long-term hearing loss and the much 
later diagnosis of an acoustic neuroma. 
The average specialist's delay remained more or less constant and in 30 out 
of the 164 patients it was longer than one year. In 27 of these cases, no 
adequate diagnostic tests had been carried out and in the remaining three 
cases, the tests themselves had been inadequate. The cause of longer delays 
can mainly be attributed to incorrect interpretation of the symptoms by the 
specialist and not to technical failure. If the diagnosis is not made within one 
year of referral to a specialist, it usually takes far longer for the diagnosis to 
be made (39.1 months versus 97.6 months). If cerebello-pontine angle 
pathology is not suspected initially, or has been excluded, this diagnosis is 
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subsequently ignored for a considerable period. The cause of a long delay is 
therefore far more often due to misjudgment by the specialist (21/30) than to 
patient or GP delay (9/30). 
Despite the enormous improvements in diagnostic techniques, recent 
experience has shown that there are still considerably long delays in 
diagnosis. The improvements of CT-scanning technique did not influence the 
delay time. It may becoming easier to avoid this situation owing to more 
accessible MRI. MRI of the cerebello-pontine angle offers now the 
opportunity to exclude an acoustic neuroma. Future investigations of delays 
may prove the expected positive influence of more extensive MRI-scanning 
of patients at rise for an acoustic tumor. The average duration until the first 
consultation with the specialist (delay 1) is over twice as long as the time 
necessary to make the diagnosis (delay 2). Greater public awareness of the 
symptoms - and GP awareness - can also shorten this first delay. Once the 
diagnosis had been made, the patients did not have to wait long for surgery 
in our clinic. 
CONCLUSION 
It is unavoidable that it may take some considerable time to make the 
diagnosis of an acoustic neuroma. The average duration before the patient 
was referred to a specialist was three years in our series. The average time 
until this specialist made the diagnosis was slightly longer than one year. 
Although the average diameter of the tumors decreased, the time that it took 
the specialist to make the diagnosis did not decrease. It is recommended to 
perform MRI of the cerebello-pontine angle if there is any suspicion of 
pathology in this region. Even patients with a long-term anamnesis of 
complaints such as asymmetrical hearing loss, tinnitus or vertigo, have the 
right to undergo MRI to exclude retrocochlear pathology. In some cases, 
more than one diagnosis may be applicable, either presenting simultaneously 
or at a later date. Our research into the thirty patients in whom the specialist 
took more than one year to make the diagnosis, showed that a retrocochlear 
tumor is not always suspected. Once a diagnosis has been "excluded", it 
does not appear to be reconsidered for quite some time. The level of hearing 
impairment can form one of the deciding factors in the choice between ABR 
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or MRI [7]. If there is any doubt, it should be kept in mind that MRI is now 
the method of excluding cerebello-pontine angle pathology with a great deal 
of certainty. ABR can help to detect false-positive MRI findings and can be 
instrumental in interpreting whether the patient has cochlear or retrocochlear 
hearing loss [8]. 
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CHAPTER Г 
Translabyrinthine and transotic surgery for acoustic neuroma 
ABSTRACT 
The results and complications of translabyrinthine and transotic surgery for 
petrous apex lesions including acoustic neuromas between 1980 and 1992 are 
presented. An acoustic neuroma was found in 52 patients. In 1988, the 
translabyrinthine approach was modified into the transotic approach and 
replaced the former technique. There was no mortality in this series, but two 
patients had mild brainstem infarcts and there was postoperative bleeding 
into the cerebellopontine angle in one. Cerebrospinal fluid (CSF) leakage 
was seen in six patients and meningitis in two. Three suffered deep vein 
thrombosis in their legs. There was one case each of herniation of the 
cerebellum and gastric bleeding. Postoperative facial nerve function was 
good in 88%, moderate in 10% and poor in 2%. In the case of acoustic 
neuroma the aim was total tumor removal, but if there was a serious rise of 
damaging the nerve anatomically, near total or subtotal removal was 
performed. During the study period, there was a gradual decrease in facial 
nerve morbidity and surgical complications. This was attributed to increasing 
experience, the modified wider approach and better postoperative care. 
INTRODUCTION 
Since the introduction of microsurgery by House in 1964 for the treatment of 
acoustic neuromas1, the otologist's contribution to this surgical procedure has 
increased dramatically. The translabyrinthine approach2 allows early 
identification of the facial nerve; thus damage can be avoided and its 
function can be retained. Nevertheless various authors, including Gantz and 
Fisch3, recommended modifying the approach. This was adopted in 
Nijmegen in 1988. 
Acoustic neuroma have been treated surgically in Nijmegen since 1973 via 
the translabyrinthine approach, but the surgeons were interested in develo­
ping a technique which would offer a wider approach to the cerebellopontine 
angle (CPA). 
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Figure 1: 
(a) Anatomy with an acoustic neuroma in situ, (b) the translabyrinthine 
approach, (c) the transotic approach. 
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After gaining experience with the modified transotic approach they decided 
to alter their approach from translabyrinthine to transotic in 1988 (figure 
1).There were two reasons for this decision: to give a wider approach to the 
CPA and to enable more adequate closure of the middle ear and the 
Eustachian tube. In the transotic approach the promontory and the cochlea 
are removed and anterior to the descending facial nerve the jugular bulb is 
skeletonized. Anteriorly the carotid artery is skeletonized as the anterior limit 
of the approach. In this way a more anterior view of the acoustic neuroma 
can be obtained and the anterior inferior artery can be seen at an earlier 
stage of the operation. A disadvantage is that the internal part of the facial 
nerve is not covered by bone. Too firm packing of the cavity at the end of 
the operation can produce a progressive facial nerve paralysis. A progressive 
facial nerve paralysis was observed twice. Therefore, in the latter part of the 
series it was decided to leave the promontory in situ if the tumor was smaller 
than 25 mm in diameter. We found it an advantage to remove the external 
acoustic canal and the tympanic membrane to have a more secure closure of 
the Eustachian tube. It reduces the incidence of CSF leakage and meningitis. 
Also it allows a wider approach for the surgical instruments and gives better 
access. 
MATERIALS AND METHODS 
In the period from 1980 to 1992, 62 patients underwent translabyrinthine or 
modified transotic surgery (figure 2). In 56 patients the indication for 
surgery was an acoustic neuroma. In the six remaining patients, three had a 
cholesteatoma10, one a cavernous haemangioma4, one had what later turned 
out to be a métastase from a haemangiopericytoma" and one had a pseudotu-
mor of the facial nerve5. In the latter three patients, it was not clear whether 
we were dealing with an acoustic neuroma and histological examination was 
necessary to make the diagnosis. Four patients with an acoustic neuroma 
were excluded, in three the operation had to be completed sub-occipitally 
because it was impossible to remove the tumor adequately via the transla-
byrinthine approach. In one patient the operation was discontinued before 
opening the cerebellopontine angle because of severe haemorrhage from the 
jugular bulb and the rise of a postoperative bleed into the CPA. 
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Our series therefore comprised 52 patients who were operated on for an 
acoustic neuroma via the translabyrinthine (N = 12) or the modified transotic 
approach (N=40). The translabyrinthine approach was modified into the 
transotic approach in 1988. 
The average age of the patients was 49.7 years (SD 12.4), with a range of 
18-69 years. The ratio of men to women was 1 : 0.86. The average hearing 
loss at frequencies of 0.5 kHz, 1 kHz and 2 kHz was 55 dB (SD 19 dB) and 
three patients had a total unilateral deafness. The average tumor size was 
16.2 mm (SD 5.6 mm). The size was estimated per-operatively by the 
surgeon to include the intrameatal part. There was good agreement with the 
radiological findings and there were very few obvious discrepancies. 
Although the size of the tumors was simular during the course of the study 
(figure 3), there were two tumors larger than 30 mm in 1990, which explains 
the peak in tumor size in that year. 
number of patients 
1980 1981 1982 1983 1984 1986 1986 1987 1988 1989 1990 1991 1992 
year of operation 
В translabyrinthine Ш modified transotic 
Figure 2: 
Surgical approach to an acoustic neuroma. 
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Three patients had a tumor size exceeding 25 mm. The operations were 
performed by otologists with the support of a neurosurgeon when there was 
difficulty in the CPA. Most of the operations were performed by a team of 
two otologists. 
The surgical results were classified in terms of the extend to which the 
acoustic neuroma could be removed: total, near total or subtotal5. We also 
examined the complications and the incidence of facial paresis, using the 
classification of House and Brackmann6. 
RESULTS 
There was no mortality in relation to the operation. The surgical complicati­
ons of the two approaches are listed in Table I: the transotic approach is 
divided in two periods. The incidence of CSF leakage and meningitis 
decreased in the latter part of the study period. There appeared to be a direct 
relationship with blind sac closure of the external acoustic canal. In the last 
two patients in whom CSF leakage occurred, there was wide pneumatization 
around the lateral part of the Eustachian tube. 
mm 
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Figure 3: 
Per-operative size of the acoustic neuromas 
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The CSF followed the hypotympanic route to fill the cells around the 
Eustachian tube. In one case, leakage was provoked by the patient playing 
music on a tuba. 
Venous thrombosis gradually disappeared, probably owing to early 
mobilization of the patients which was started on the second postoperative 
day with short periods out of bed. There were two patients with very mild 
postoperative brainstem infarction. There was one patient with a gastric 
bleed from a pre-existing stress ulcer. 
Recently we encountered one patient with bleeding in the CPA which was 
probably the result of a hypertensive crisis provoked by severe hypothermia 
(±34° Celsius) at the end of the operation. Sedation was given as part of the 
treatment. The elevated pressure in the CPA went unnoticed and probably 
became too high despite treatment for the hypertensive crisis. CT scanning 
was performed 3 days after the operation because of progressive facial palsy, 
sixth nerve paralysis and partial hemiparesis. The hemiparesis improved to 
some extent but incompletely. The facial paralysis did not improve. 
The tumor was totally removed in 42 out of the 52 patients. If the tumor was 
attached too firmly to the facial nerve, a few millimetres of tumor were left 
in situ to avoid damaging the nerve. Near total removal (according to 
Kartush and Lundi5) was performed in three out of the 52 patients and 
probably had a favourable effect on facial nerve function. Subtotal removal 
was performed in nine out of the 52. In one of these patients with a tumor 
diameter of 35 mm, herniation of the cerebellum occurred, so only subtotal 
excision was possible. 
In another patient the jugular bulb was accidentally opened by drilling and 
since this was considered a great rise of postoperative bleed into the CPA the 
operation was abandoned.The patient requested radiodiagnostic follow-up 
instead of surgery via the suboccipital approach. During a 6-year follow-up 
period with CT-scanning and later MRI, there was no evidence of tumor 
growth. At the beginning of the study period, it was not always possible for 
total or subtotal removal in a one-stage procedure via the translabyrinthine 
approach. This was later considered to be the result of limited access to the 
CPA. 
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Table 1: 
Postoperative complications after translabyrinthine (1980-1988, N=12) and 
transotic (1988-1992, N=40) surgery. 
Period: 1980-1988 1988-1990 1991-1992 1980-1992 
Approach: translab. transotic transotic translab/otic 
mortality 
brainstem infarction 
haemorrhage in CPA 
CSF leakage 
meningitis 
venous thrombosis 
herniation of cerebellum 
stomach bleeding 
0/12 
1/12 
0/12 
2/12 
1/12 
1/12 
0/12 
1/12 
0% 
8% 
0% 
17% 
8% 
8% 
0% 
8% 
0/22 
1/22 
0/22 
3/22 
1/22 
2/22 
1/22 
0/22 
0% 
5% 
0% 
14% 
5% 
9% 
5% 
0% 
0/18 
0/18 
1/18 
1/18 
0/18 
0/18 
0/18 
0/18 
0% 
0% 
6% 
6% 
0% 
0% 
0% 
0% 
0/52 
2/52 
1/52 
6/52 
2/52 
3/52 
1/52 
1/52 
0% 
4% 
2% 
12% 
4% 
6% 
2% 
2% 
Figure 4: 
Facial nerve function after 1 year of tumours not exceeding 25 mm 
62 Translabyrinthine and transotic surgery 
Good facial nerve function (grades I and II) was seen in 46 patients (88%) 
after a follow-up of at least 12 months. In five patients (10%) function was 
moderate (grades III and IV) and in one patient (2%) it was poor (grade VI). 
In figure 4 the results of the facial nerve function are presented of patients 
with a tumor of 25 mm and less (N=49). There is no influence of the results 
of the three patients with larger tumors, all with grade I, in this distribution. 
In one patient the facial nerve was damaged during the operation and a 
hypoglossal facial anastomosis was performed, which resulted in grade III 
function. 
Tables 2 and 3 show the facial nerve function direct after the operation (1 
week postoperatively, Table 2) and after one year (Table 3) in four 
consecutive study intervals. There was a gradual decrease in the incidence of 
grades III to VI results after 7 days over the four periods. Two patients had 
a progressive total facial palsy after the operation using the modified 
transotic approach. This may have been caused by unsuccessful suturing of 
the dura or by too firm packing of the surgical cavity with fat. Athough we 
only encountered two such cases, it was later decided to leave the promonto-
ry intact in patient with a tumor diameter of less than 2.5 cm. Fortunately 
the facial nerve of one of these patients recovered later; after 2 years the 
facial paresis was diagnosed as grade IV. 
DISCUSSION 
Various surgical approaches can be used for an acoustic neuroma. The 
choice of technique depends on a number of factors, such as the experience 
of the surgeon and the size of the tumor. Other important factors include the 
severity of the patient's hearing loss and his or her own wishes. The most 
important aims during surgery are total removal of the tumor, avoidance of 
major neurological complications, preservation of facial nerve function and if 
possible, preservation of hearing. 
In our series, preoperative hearing levels were generally fairly poor and 
formed an important part of the decision to operate using the translabyrinthi-
ne or transotic approach. In the Tables, various study intervals were 
compared. They show that increasing experience and modification of the 
surgical technique gradually led to better results and fewer complications. 
This is in agreement with other larger series7,8. 
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Table 2: 
Facial nerve function 7 days after the translabyrintine approach (1980-1988, 
N=12) and the transotic approach (1988-1992, N=40). 
period 
1980-1984 
1985-1988 
1988-1990 
1991-1992 
1980-1992 
approach 
translab (6) 
translab (6) 
transotic (22) 
transotic (18) 
translab/otic (52) 
Normal 
(Grade 1,11) 
2/6 
3/6 
17/22 
14/18 
36/52 
(33%) 
(50%) 
(77%) 
(78%) 
(69%) 
Paresis/Paralysis 
(Grade III-VI) 
4/6 
3/6 
5/22 
4/18 
16/52 
(66%) 
(50%) 
(23%) 
(22%) 
(31%) 
Modification of the surgical technique also reduced the number of other 
complications, such as CSF leaks and meningitis. Early postoperative 
mobilization of the patients helped to prevent venous thrombosis. It was not 
always possible to achieve total excision of the tumor. The choice between 
severe morbidity or even mortality and subtotal excision is obvious. If the 
tumor is firmly attached to the facial nerve, the choice is not as simple. 
Total excision in such cases may mean that damaging the facial nerve is 
unavoidable. We find it preferable to perform total removal of the tumor, but 
sometimes it is necessary to perform near total or subtotal removal in order 
to spare the facial nerve. 
In comparison with some other series in the literature, our study population 
was fairly small. The results showed gradual improvement over the study 
interval. Regular follow-up evaluations and modification of the surgical 
technique and postoperative care led to a decrease in the number of 
complications. 
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Table 3: 
Facial nerve function in the follow up (one year after operation) after the 
translabyrintine and transotic approach 
period 
1980-1984 
1984-1988 
1988-1990 
1990-1992 
1980-1992 
approach 
translab (6) 
translab (6) 
transotic (22) 
transotic (18) 
translab/otic (52) 
Normal 
(Grade 1,11) 
6/6 
6/6 
19/22 
15/18 
46/52 
(100%) 
(100%) 
(86%) 
(83%) 
(88%) 
Paresis/Paralysis 
(Grade III-VI) 
_ 
-
3/22 
3/18 
6/52 
(14%) 
(17%) 
(12%) 
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CHAPTER V 
Suboccipital surgery for acoustic neuroma 
ABSTRACT 
A retrospective study was performed on 106 consecutive patients with an 
acoustic neuroma who underwent suboccipital surgery for the first time 
between 1980 and 1992. Complete follow-up data were available for all the 
patients, including regular imaging of the pontine angle up to 1 January 
1994. The results of surgery were compared to those obtained at other 
centres where the same surgical approach was used and also to the results of 
other approaches used in Nijmegen and elsewhere. 
Incomplete removal of the tumours had taken preference to radical surgery in 
a large proportion of the patients, to avoid the risk of postoperative 
morbidity. The recurrence rate in this series was 20%. Comparison of the 
results of suboccipital surgery to those obtained using other surgical 
approaches, while taking the tumour size into consideration, showed that 
better results can be obtained after total removal of the tumour without any 
additional risk to postoperative facial nerve function. The long-term results of 
subtotal removal using the suboccipital approach were disappointing. It is 
therefore necessary to review the indications for non-radical surgery in 
patients with an acoustic neuroma. 
INTRODUCTION 
Various techniques have been developed for the removal of an acoustic 
neuroma. To decide which of these techniques is the most suitable for a 
particular patient, it is necessary to consider his/her age, the level of hearing 
loss on the affected side, the experience and preference of the surgeon. At 
the Nijmegen University Hospital, the Netherlands, the majority of patients 
with an acoustic tumour have been operated on using the suboccipital or 
translabyrinthine/transotic approach1. Follow-up results are available over a 
period of 13 years. 
A retrospective study was performed to evaluate the effect of the radicality 
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of surgery, tumour size and surgical approach, in relation to preoperative 
and postoperative hearing levels, long-term postoperative facial nerve 
function and tumour recurrence. 
PATIENTS AND METHODS 
In the period from 1980 to 1992, 194 consecutive suboccipital trepanation 
procedures were performed at the University Hospital Nijmegen, the 
Netherlands. A total of 106 patients had a unilateral acoustic neuroma which 
had not been operated on previously. In the remaining 88 procedures, 48 
patients were found to have a different histological pathology: 4 of them had 
Neurofibromatosis type II and one patient had two operations. One patient 
had undergone previous surgery for an acoustic neuroma but had later 
developed a non-Hodgkin lymphoma in the contralateral pontine angle. In the 
period before 1980, 5 tumour recurrences were operated on. In three 
patients, previous incomplete translabyrinthine exploration had been carried 
out and a second operation was necessary. The remaining 27 suboccipital 
operations were performed for tumour recurrence after surgery during the 
period from 1980 to 1992. 
In this study we analysed the results of the 106 consecutive patients with an 
acoustic neuroma who were operated on for the first time between 1980 and 
1992. We found that 21 patients (20%) had developed one or more tumour 
recurrences in the follow-up period up to and including 1 January 1994. Six 
out of these 21 re-operations were performed in 1993. A total of 139 
surgical procedures were carried out. All the data were obtained in retrospect 
from the patients' fully up-to-date medical files. Tumour size was measured 
postoperatively and compared to the already available radiological findings. 
The diameter of the whole tumour was measured, including the intrameatal 
part (if present). The function of the facial nerve was classified according to 
House and Brackman2. 
The operations were conducted at the Neuro-surgery Department with the 
patients lying prone or on their side. The neurosurgeon generally performed 
the suboccipital trepanation procedures in cooperation with an ENT surgeon. 
After exposing the medial part of the tumour, the internal acoustic meatus 
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was opened so that the facial nerve could be identified. 
The quantity of tumour excised was classified into total, near total and 
subtotal removal3. With total removal, the surgeon did not leave any clinical 
evidence of the tumour; with near total removal, a fragment of the tumour or 
the capsule was left in situ; with subtotal removal, a measurable quantity of 
the tumour was left in situ. In all the cases, the aim was total extirpation, 
while sparing the surrounding structures. It should be emphasized that in 
cases where it was necessary to choose between conservative treatment and 
total removal, the choice was usually near total or subtotal removal. This 
was based on the decision that re-operation was preferable to a greater risk 
of morbidity, particularly of the facial nerve after total removal. Central 
issues were the choice between radicality, the risk of neurological deficits, 
conservation of facial nerve function and the possible need for reoperation. 
RESULTS 
The mean age of the patients with an acoustic neuroma at the time of (first) 
surgery was 49.5 years (SD 14.9 years). The mean tumour size of the 
primary acoustic neuromas was 32.3 mm (SD 12.5 mm), with a range of 10 
to 72 mm. A total of 32 tumours were smaller or equal to 25 mm; 57 
tumours were between 26 and 40 mm; and 17 tumours were larger than 40 
mm. The study group was selected from all the patients who presented with 
an acoustic neuroma at the University Hospital Nijmegen. The remaining, 
usually smaller tumours (N=56, mean diameter 16.2 mm, SD 5.6 mm) were 
operated on via the translabyrinthine or transotic approach and have been 
described elsewhere ('). 
Selection criteria for the various approaches included the diameter of the 
tumour, the condition of the patient, the presence of adequate hearing on the 
affected side; another factor which played a role was whether the patient had 
originally been referred to the neuro-surgery department or the ENT 
department. 
In 23% of the patients (24/106) total removal had been performed and in 8% 
(9/106) near total removal. For the majority of patients (69%; 73/106) 
subtotal removal had been the method of choice. 
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Table 1: 
Correlation between tumor diameter; total vs near total vs subtotal removal; 
and mean age of the patients (at time of the first operation) 
tumor diameter/removal 
1-25 mm 
total removal 
16/32 = 50% 
50.1 years 
near total removal 
4/32 = 13% 
49.8 years 
subtotal removal 
12/32 = 37% 
49.6 years 
26-40 mm 6/57 = 11! 
46.5 years 
4/57 = 79 
55.0 years 
47/47 = 82% 
49.3 years 
> 40 mm 2/17 = 12% 
53.5 years 
1/17 = 69 
50 years 
14/17 = 82% 
44 years 
all sizes 24/106 = 23% 9/106 = 89 73/106 = 69% 
Table 2: 
Complications of suboccipital surgery for acoustic neuroma 
complication 
death 
hemorrhage CP angle 
hemorrhage cerebrum 
postoperative hydrocephalus 
CSF leakage 
meningitis 
leasion or infarction cerebellum 
dysartria/dysfagia 
facial nerve transection 
cerebellar oedema 
lung embolus 
intra-operative heart arrest 
trigeminal dysfunction 
abducens dysfunction 
diplopia 
urinary tract infection 
bronchial infection 
diabetic dysregulation 
this series. 
1/106 
5/106 
4/106 
4/106 
7/106 
1/106 
4/106 
2/106 
4/106 
2/106 
1/106 
1/106 
3/106 
2/106 
3/106 
4/106 
2/106 
1/106 
endresult 
1% 
5% 
4% 
4% 
7% 
1% 
4% 
2% 
4% 
2% 
1% 
1% 
3% 
2% 
3% 
4% 
2% 
1% 
after the first operation 
0 
4/106 
1/106 
2/106 
4/106 
1/106 
4/106 
0 
4/106 
2/106 
1/106 
1/106 
3/106 
2/106 
3/106 
1/106 
0 
2/106 
4% 
1% 
2% 
4% 
1% 
4% 
4% 
2% 
1% 
1% 
3% 
2% 
3% 
1% 
2% 
after residual surgery 
1/33 
1/33 
3/33 
2/33 
3/33 
0 
0 
2/33 
0 
0 
0 
0 
0 
0 
0 
3/33 
2/33 
0 
3% 
3% 
9% 
6% 
9% 
6% 
9% 
6% 
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Table 1 shows the correlation between tumour diameter, near total removal, 
subtotal removal and the mean age of the patients.Surgical complications are 
presented in Table 2. The first column lists the complications which occurred 
in the whole series after one or more operations up to the end of 1993. The 
second column lists the complications in the group of 106 patients after their 
first operation and the third column lists the complications after surgery for 
tumour recurrence (21 patients underwent 33 surgical procedures). 
The complications were also analysed in relation to the size of the primary 
tumour and all the operations required, including possible re-operations 
(Table 6A). 
Hearing on the affected side was tested preoperatively using tone audiome­
try and in most cases also speech audiometry. In 93/106 patients (88%), a 
preoperative hearing threshold was measured. 
A hearing loss of 30 dB or less on the pure tone audiogram and a score of at 
least 70% for speech recognition (* Shelton) was found in 13/106 (12%); a 
hearing loss of 50 dB or less and a score of at least 50% for speech 
recognition was found in 40/106 (38%); the remaining 40/106 patients had 
much poorer hearing (>50 dB hearing loss and <50% speech recognition). 
Preoperatively, 13/106 patients (12%) were totally deaf. The thresholds of 
30 dB/70% and 50 dB/50% are open to question. We used the classification 
employed in the literature solely for the purpose of describing and comparing 
the levels of hearing loss to those found in other series of patients. 
Table ЗА shows the classification of the mean preoperative and postoperative 
hearing loss (Fletcher Index) at 0.5, 1.0 and 2.0 kHz in steps of 10 dB per 
tumour diameter for the total series. Table 3B shows the preoperative and 
postoperative scores for speech recognition in steps of 10% per tumour 
diameter for the total series. 
Unfortunately postoperatively in most patients occurred deafness on the 
operated side, in 63 patients who had been able to hear preoperatively 
(63/93 = 68%). The preoperative hearing threshold of 93 operated ears (with 
no more regard to the 13 preoperative already deaf ears) was not totally lost 
in 30 patients (30/93=32%). In 8 of these 30 patients there was even a mean 
hearing improvement of 18 dB. 
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Table ЗА: 
Pure tone audiometry: Preoperative (pre)(N=103) and postoperative 
(post)(N = 106) hearing loss of patients per tumor diameter. Mean hearing 
loss at three frequencies (0.5, 1.0 and 2.0 kHz) (Fletcher Index). 
tumor diameter/ 1-25 mm 26-40 mm >40mm all sizes 
fletcher index pre post pre post pre post pre post 
0-10 dB 
11-20 
21-30 
31-40 
41-50 
51-60 
61-70 
71-80 
81-90 
>90dB 
unknown 
N = 
0 
3 
2 
10 
4 
5 
5 
1 
1 
1 
32 
0 
1 
0 
2 
2 
1 
2 
0 
0 
24 
32 
1 
2 
6 
8 
8 
7 
6 
4 
2 
10 
3 
57 
0 
2 
1 
1 
2 
3 
4 
1 
0 
43 
57 
2 
1 
2 
2 
2 
1 
4 
0 
0 
3 
17 
0 
0 
1 
2 
1 
1 
0 
2 
0 
11 
17 
3 
6 
10 
20 
14 
13 
15 
5 
3 
14 
3 
106 
0 
3 
2 
5 
5 
5 
6 
2 
0 
78 
10 
The postoperative hearing results of the 30 patients can be demonstrated as 
followed. Hearing with a maximum of 30 dB loss and at least 70% speech 
recognition was found in 4 patients (4/93=4%); a maximum of 50 dB loss 
and at least 50% speech recognition was found in 11 patients (11/93 = 12%); 
and more than 50 dB loss with less than 50% speech recognition was found 
in 15 patients (15/93 = 16%). 
Prior to surgery, grades I and II facial nerve function were present in 93/106 
patients (88%), grades III and IV in 8/106 patients (8%) and grades V and 
VI in one patient (1%). 
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Table 3B: 
Speech audiometry: maximum preoperative (pre)(N=68) and postoperative 
(post)(N = 63) speech recognition for 3 tumor diameters 
tumor diameter/ 
speech recognition 
91-100% 
81-90% 
71-80% 
61-70% 
51-60% 
41-50% 
31-40% 
21-30% 
11-20% 
0-10% 
unknown 
N = 
1-25 mm 
pre 
4 
7 
4 
2 
2 
2 
1 
1 
0 
1 
8 
32 
post 
2 
1 
0 
2 
0 
0 
0 
0 
0 
15 
12 
32 
26-40 mm 
pre 
6 
3 
3 
6 
3 
3 
2 
0 
2 
9 
23 
57 
post 
1 
0 
0 
0 
0 
0 
1 
0 
0 
29 
29 
57 
>40 mm 
pre 
2 
1 
0 
2 
0 
0 
1 
1 
0 
3 
7 
17 
post 
2 
0 
0 
0 
0 
0 
0 
0 
0 
10 
5 
17 
all sizes 
pre 
12 
11 
7 
10 
5 
5 
4 
2 
2 
13 
38 
106 
post 
5 
1 
0 
2 
0 
0 
1 
0 
0 
54 
43 
106 
In 4 cases the preoperative function was unknown and the data were not 
retrievable. At one-year follow-up, facial nerve function after the last (re-
operation was good (grades I and II) in 63/106 patients (60%), moderate 
(grades III and IV) in 29/106 patients (27%) and poor (grades V and VI) in 
14/106 patients. Table 4 shows the grades of facial nerve function for the 
total series per tumour diameter. In Figure 1, the grades of facial nerve 
function are presented per tumour diameter and per extent of tumour 
removal. 
The patients in this series were followed-up using CT scanning with an 
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intravenous contrast medium; since 1988 a proportion have also been 
followed using MRI with Gadolinium. The duration of follow-up was at least 
one year (ranging from 12 to 156 months). Tumour recurrence occurred in 
21 patients. In 12 patients there was one episode of residual tumour growth; 
11 of them had undergone subtotal removal and one near total removal. Six 
patients were operated on twice for tumour recurrence. In 5 out of these 6 
cases the tumour had been removed subtotally and in one near totally. Three 
patients whose primary operation had involved subtotal removal, had 3 re-
operations each. 
In the original group of 73/106 patients with subtotal removal, 19/73 (26%) 
developed tumour recurrence. In the group of 9/106 patients with near total 
removal, 2/9 developed tumour recurrence (22%). There were no cases of 
tumour recurrence after total removal. 
Table 4: 
Tumor diameter versus facial nerve function in House grades: preoperative 
facial nerve function and results after suboccipital surgery 
House grade 
Preoperative function of the facial nerve (N = 102)' 
< 25 mm 
26-40 mm 
> 40 mm 
all sizes 
Results after surgery with all reoperations (N = 106) 
< 25 mm 
26-40 mm 
> 40 mm 
all sizes 
I 
29 
39 
12 
80 
12 
21 
6 
39 
II 
2 
7 
4 
13 
7 
15 
2 
24 
III 
0 
5 
2 
7 
7 
8 
2 
17 
rv 
0 
1 
0 
1 
2 
7 
3 
12 
V 
0 
0 
1 
1 
2 
3 
1 
6 
VI 
0 
0 
0 
0 
2 
3 
3 
8 
Results after surgery without re-operations (N=85) 
all sizes 36 20 12 8 
Results after surgery only re-operations (N=21) 
all sizes 3 4 5 4 
' In 4 patients preoperative facial nerve function was unknown. 
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> 40 mm (N=17) 
Figure 1: 
Grades of facial nerve function per tumor diameter and extend of removal. 
1,11; III.IV; and V.VI; House grades 
total=total removal; near total=near total removal and subtotal=subtotal 
removal 
The mean diameter of the recurrent tumours was 38.8 mm (SD 10.2 mm, 
range 20-60 mm), which was somewhat larger than the primary tumours. In 
the 32 patients with a tumour diameter of less than or equal to 25 mm who 
were operated on via the suboccipital route, there were 2 cases of recurrence 
(6%); in the group of 57 with a tumour diameter of between 25 and 40 mm 
there were 14 recurrences (25%) and in the group of 17 with a tumour 
diameter larger than 40 mm there were 5 recurrences (29%). In this series, 
there were no cases of tumour recurrence in the patients with a tumour 
diameter of less than 20 mm. 
The mean interval between the primary operation and the first reoperation 
for tumour recurrence was 3.0 years. A second reoperation took place after a 
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mean interval of 2.0 years and a third reoperation after 1.8 years. 
At the time of the primary operation, the mean age of the patients with 
tumour recurrence (49.5 years) was lower than the mean age of the total 
series; the mean age of the patients who only had one tumour recurrence was 
44.3 years (N=21, SD 13.4); the mean age of the patients who had two 
tumour recurrences was 39.6 years (N=9, SO 16.2); the mean age of the 
patients who had three tumour recurrences was 36 years (N=3, SD 11.9). 
The time necessary for tumour recurrence to develop became gradually 
shorter after each recurrence, probably due to negative selection. 
In Table 4, the facial nerve function of the patients who underwent surgery 
for tumour recurrence (N=21) is compared to that of the patients who only 
underwent one operation (N=85), without taking the tumour diameter into 
consideration. Grades I and II were found in 56/85 (66%) and in 7/21 
(33%); grades III and IV were found in 20/85 (24%) and in 9/21 (43%); and 
grades V and VI in 9/85 (10%) and in 5/21 (24%), respectively. 
DISCUSSION 
Various aspects of surgery for acoustic neuromas were analysed in this 
retrospective study. Distinction was made between the results of the total 
series of patients (including re-operations) and those who underwent surgery 
for tumour recurrence. In Nijmegen, a conservative approach was usually 
chosen via the suboccipital route. This generally led to an acceptable 
postoperative facial nerve function, compared to other series with the same 
approach in the literature, and helped to avoid the risk of major neurological 
function disturbances. 
The suboccipital and retrosigmoid approaches have been used for many years 
to treat acoustic neuromas. We found considerable differences in the extent 
of radicality, postoperative complications and facial nerve function results 
between several centres which have been using these approaches5·6·7,8,9. The 
extent of radicality in this series differed strongly from reports in the 
literature owing to our conservative technique (Table 5). In some reports, a 
distinction was made only between total and subtotal excision5,7. Complicati-
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ons were relatively more frequent in cases with larger tumours. In our 
series, we observed a steady increase in the number of cases with hae-
morrhage in the CPA and cerebrum, transection of the facial nerve and 
lesions or infarctions in the cerebellum (Table 6A). The number of surgical 
mortalities, haemorrhages in the CPA and transected facial nerves was much 
higher than average in the series described by Charabi et al.5, which the 
authors attributed to the decentralisation of suboccipital surgery in Denmark. 
Mortality rates reported by Welch & Dawes9 were also higher than those in 
similar series. The differences in the frequency of other complications was 
fairly small (Table 6B). 
Postoperative facial nerve function results in the series investigated by 
Charabi et al.5 and by Welch & Dawes9 were less favourable (Table 7A). 
The results of the other series in which the same approach was used were 
fairly similar. It was striking that in our series in which the suboccipital 
approach was used, the diameter of the tumour had very little influence on 
postoperative facial nerve function (Fig. 1). However, the number of 
complication increased with the tumour diameter (Table 6A). 
Table 5: 
Extent of radicality and number of re-operations with suboccipital and 
retrosigmoid surgery at various centres 
Ulis seríes Charabi Ebersold Pauw Pfaltz Welch 
centre 
year of publication 
number of patients 
total removal 
near total removal 
subtotal removal 
reoperations 
Nijmegen Copenhagen Rochester Rotterdam Basel Newcastle 
1994 1992 1992 1992 1991 1985 
106 59 256 82 80 77 
24 (23%) 32 (69%) 249 (97%) 71 (87%) not 65 (84%) 
9 (8%) 6 (2%) mentioned 2 (3%) 
17 (31%) 11 (13%) 
73 (69%) 1 (1%) 10 (13%) 
21 (20%) 10 (18%) 1 (1%) 0 (0%) not 
mentioned 
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Table 6A: 
Main complications and tumor diameter 
tumor diameter/ 
complication 
death 
hemorrhage in CPA 
CSF leakage 
menigitis 
facial nerve transection 
hemorrhage in cerebrum 
lesion or infarct 
of cerebellum 
1-25 mm 
0/32 
0/32 
4/32 
1/32 
0/32 
0/32 
0/32 
26-40 mm 
1/57 
3/57 
1/57 
0/57 
1/57 
2/57 
2/57 
> 40 mm 
0/17 
2/17 
2/17 
0/17 
3/17 
2/17 
2/17 
all sizes 
1/106 
5/106 
7/106 
1/106 
4/106 
4/106 
4/106 
Table 6B: 
Main complications in suboccipital en retrosigmoidal surgery in this series 
and several other studies 
author this series Charabi Ebersold Pauw Pfaltz Welch 
centre 
year of publication 
approach 
death 
hemorrhage in CPA 
CSF leakage 
meningitis 
Nijmegen Copenhagen Rochester Rotterdam Basel Newcastle 
1994 1992 1992 1992 1991 1985 
SO SO RS RS RS SO 
1/106 1% 5/59 8% 2/256 1% 1/82 1% 0/80 0% 4/77 5% 
5/106 5% 5/59 8% 0/256 0% * * 3/77 5% 
7/106 7% 3/59 5% 28/256 11% 2/82 2% 2/80 3% 3/77 4% 
1/106 1% 3/59 5% 2/256 1% 3/82 4% 3/80 4% 1/77 1% 
facial nerve transection 4/106 4% 19/59 32% 19/256 7% 13/82 16% 4/80 5% * 
hemorrhage in cerebrum 4/106 4% 2/59 3% 0/256 0% * * 3/77 4% 
lesion or infarct 
cerebellum 4/106 4% * 0/256 0% 1/80 1% 2/77 3? 
* = not mentioned 
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Table 7A: 
Postoperative facial nerve function after suboccipital surgery in this series 
(percentages of patients in House grades) compared to other centres 
centre 
year of publication 
number of patients 
tumor size 
approach 
this series 
Nijmegen 
1994 
106 
all 
SO 
Charabi 
Copenhagen 
1992 
59 
all 
SO 
Ebersold 
Rochester 
1992 
255 
all 
RS 
Pauw 
Rotterdam 
1992 
82 
all 
RS 
Pfaltz 
Basel 
1991 
80 
all 
RS 
Welch 
Newcastle 
1985 
77 
all 
SO 
100% 
II 
80% 
III 
60% 
IV 
40% 
V 
20% 
VI 
0% 
36% 
23% 
16% 
11% 
6% 
9% 
0% 
10% 
12% 
12% 
57% 
52% 
12% 
15% 
57% 
9% 
4% 
22% 
2% 
19% 
27% 
26% 
30% 
40% 
13 % 
47 % 
16% 
SO = suboccipital approach, RS = retrosigmoidal approach 
* this series was primairly selected for hearing conservation 
Differences were found between the results of facial nerve function achieved 
at other centres10·11'12,13'4 which also used other approaches than the suboccipi-
tal and retrosigmoid approaches (Table 7B). The results were analysed in 
relation to tumour diameter. Tos et al.11 used the translabyrinthine approach 
and reported considerably better results for all tumour diameters than those 
mentioned in the literature or obtained in our series using the suboccipital 
and retrosigmoid approach. For patients with small tumours, the results after 
middle fossa or translabyrinthine and transotic approaches were better than 
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those after suboccipital surgery. In our series of translabyrinthine and 
transotic surgery' patients with a tumour diameter of less than 35 mm, we 
also obtained better facial nerve results, which is in agreement with the 
literature on these approaches. Table 7B also shows the results of Sterkers et 
al10. For some time they have been using the suboccipital approach at their 
centre instead of the translabyrinthine approach, in order to preserve the 
patients' hearing. The application of the suboccipital technique has not led to 
better facial nerve function results. 
A frequently mentioned advantage of suboccipital surgery is that it is 
possible to preserve the patient's hearing. However, this has only proved to 
be feasible to a limited extent. In this series, hearing could be preserved in 
32% of the patients and in 16% it was either good or acceptable. Tables 1A 
and IB show that fairly commonly, little remains of good preoperative 
hearing after the operation. If the primary aim is to preserve the patient's 
hearing, the (extended) middle fossa approach seems to be the method of 
choice13,4. 
Besides preservation of good neurological function, radicality has also been 
mentioned as one of the conditions that is necessary for successful surgery. 
Conservative surgery, as was applied in our series, was expected to produce 
better results. The long-term results in our total suboccipital series are 
comparable with those obtained at other centres. It was notable that the 
results after multiple operations were clearly poorer. The number of 
complications increased. In the group of re-operations, one patient died in 
the postoperative period from haemorrhage in the brain stem. Furthermore, 
the higher percentage of patients with postoperative haemorrhage in the 
CPA, hydrocephalus and CSF leakage was also disquieting. There was also a 
higher percentage of bronchial and urinary infections after multiple 
operations. It was striking that the mean age of the patients who developed 
tumour recurrence was relatively low. Therefore, more advanced age should 
not play a role in whether or not radical excision should be performed. The 
extent of radicality depended on the diameter of the tumour in this series. A 
greater proportion of the patients with larger tumours underwent subtotal 
excision. There was a relationship between increasing diameter and 
decreasing radicality (Table 2). 
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Table 7B: 
Postoperative facial nerve function in this series compared to other appro­
aches and other centres, with percentages of patients in House grades. 
Ulis series Sterkers Tos Leeuwen Fisch Haid Shelton 
centre Nijmegen Paris Copen- Nijmegen Zurich Erlangen Los Angeles 
hagen 
year of publication 1994 
number of patients 106 
tumor diameter all 
approach SO 
1994 1992 1994 1988 1992 1989 
571 400 52 66 154 92 
< 40 mm all < 35 mm < 25 mm < 35 mm * 
RS/TL/MF TL TL/ТО TO MF MF 
I 
100% 
II 
80% 
36% 
23% 
63% 
67% 78% 70% 53% 815 
12% 10% 15% 25% 9% 
III 
60% 16% 19% 3% 4% 9% 20% 
IV 
40% 11% 12% 4% 4% 
V 
20% 
VI 
6% 4% 0% 
6% 35 
8% 10% 4% 
SO = suboccipital approach, MF = middle fossa approach, TL = translabyrinthine approach, TO = 
transo tic, approach, RS = retrosigmoidal approach, * this series was primairly selected for hearing 
conservation. 
It took several years for tumour recurrence to become manifest. This is an 
important factor to take into consideration when planning adequate follow-
up, as has also been mentioned by others14. 
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In the literature, there are many reports on the indications for subtotal 
excision of an acoustic neuroma14,15,1617. These include changes in vital signs 
during surgery, advanced age and high surgical risk14. In addition, it is not 
always possible to remove the entire tumour without causing additional 
neurological deficits15. In a study published in 1957 by Pool18, tumour 
recurrence was observed in 25 out of the 123 patients who underwent 
suboccipital surgery (20%). Olivecrona19 found 11 cases of tumour recurren-
ce in 52 patients after subtotal suboccipital excision (21%). In this series, we 
encountered a recurrence rate of 20%, which is in good agreement with the 
above-mentioned studies. Shea20 reported tumour recurrence in 12 out of 33 
subtotal suboccipital excisions (36.3%) from an original series of 200 
patients who were treated from 1964 to 1967 and followed-up for 20 years. 
The indications for subtotal removal employed in this series were not as 
strict as those mentioned in the literature, which might explain the high 
percentage of 69% of patients who were consciously selected for subtotal 
removal. A further 8% underwent near total removal. 
In retrospect, the value of subtotal excision of an acoustic neuroma, which 
has been applied so frequently, seems questionable. The initially favourable 
results became undermined by the poorer results of re-operations in the long-
term. The high recurrence rate found in this series and the disappointing 
results of multiple operations, form strong arguments against the application 
of less radical surgery for an acoustic neuroma. When we compared the 
results of suboccipital surgery to those obtained with the translabyrinthine 
and transotic approaches, various important aspects arose. For instance, the 
translabyrinthine and transotic approaches repeatedly led to better facial 
nerve function results, especially in patients with a maximum tumour 
diameter of 25 mm. Arguments in favour of using the translabyrinthine and 
transotic approaches are gaining strength, while the arguments in favour of 
the suboccipital approach, such as preserving the patient's hearing, are 
steadily losing ground. 
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CHAPTER VI 
Quality of life after acoustic neuroma surgery 
ABSTRACT 
A questionnaire was completed by 134 patients who had undergone surgery 
for a unilateral acoustic neuroma between 1980 and 1993, to obtain data on 
the consequences on their quality of life, postoperative physical condition, 
social life, employment and the use of medical facilities. Distinctions were 
made between the translabyrinthine/transotic approach, the suboccipital 
approach, tumor size and the number of operations per patient. We found 
that the patients ' reported state of health after surgery was poorer than that 
in a group of comparable non-operated patients. Recuperation after an 
operation took many months and did not always result in full recovery. 
Surgery had various effects on preoperative symptoms such as hearing loss, 
tinnitus, vertigo and facial nerve dysfunction: improvement, no change or 
deterioration. Surgery had severe consequences on social life and occupati-
on, but far less effect on income. Almost one third of the patients required 
postoperative home help and a proportion were declared unfit to work. The 
surgical approach, tumor size and reoperations had a definite influence on 
the study parameters. After suboccipital surgery, there were more reports of 
pain, more declarations of incapacity to work, poorer facial nerve function 
and more frequent visits to the general practitioner (GP). The translabyrin-
thine/transotic approach was associated with more severe pain and more 
complaints of postoperative vertigo. A greater proportion of the patients with 
larger tumors were declared unfit to work. General state of health after 
suboccipital reoperations was better than after the initial operation; there 
was no reasonable explanation for this. Facial nerve Junction deteriorated 
after reoperation^). 
INTRODUCTION 
A patient's subjective assessment of the outcome of therapy is an important 
measure of therapeutic success. Whereas many reports have been published 
in the literature on the results of acoustic neuroma surgery after various 
approaches to various tumor diameters, the subjective opinion of the patient 
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about the postoperative period has received far less attention. Parving1 and 
Wiegand2 mentioned a decrease in the quality of life after acoustic neuroma 
surgery. Surgical intervention can strongly influence the daily life of the 
patient. The consequences of the intervention on tumors of the same 
diameter can vary depending on the choice of surgical approach. So far, no 
research has been conducted in which a comparison was made between the 
effects of tumor size, various approaches and reoperations. At the University 
Hospital Nijmegen, patients with an acoustic neuroma can be operated on via 
the suboccipital approach or via the translabyrinthine/transotic approach. 
Although the suboccipital approach is used for the majority of large tumors 
and the translabyrinthine/transotic approach for the majority of small tumors, 
the overlap in tumor size means that a fairly reliable comparison can be 
made. Many different effects of tumor size, approach and reoperations can 
be expected. Larger tumors may have more postoperative consequences on 
the quality of life than smaller ones. Surgical results have shown remarkable 
differences in facial nerve function in relation to the number of 
reoperations3,4. Reoperations after subtotal removal may lead to greater 
morbidity. The results of our quality of life measurement were also 
compared to those of a group of non-operated Dutch inhabitants. The 
outcome of the study may be used for patient education, to assist in the 
choice of approach and to encourage further research. 
PATIENTS AND METHODS 
In the period from 1980 to the end of 1993, 176 patients were operated on 
for a unilateral acoustic neuroma at the University Hospital Nijmegen. The 
suboccipital approach was used in 108 patients and the translabyrinthine or 
(modified) transotic approach in 66 patients. Two patients were operated on 
via the middle fossa approach and were excluded from the study. 
In May 1994, the remaining 174 patients were sent a questionnaire with an 
instruction sheet about how to fill it in. The questionnaire comprised three 
sections: the consequences of the operation on (a) quality of life, (b) physical 
condition and (c) the use of medical facilities. The results are discussed per 
section. 
Quality of life was measured using generic and disease-specific measurement 
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instruments and a number of questions about changes in relation to home 
help requirement, work (resuming work, being declared unfit to work) and 
income. The generic and disease-specific measures for quality of life are 
described briefly below. 
The standard question of the CBS (Dutch Central Bureau of Statistics) was 
used to measure the state of health: "What is your general state of health?". 
We inquired about the patient's state of health at that time. Answers could be 
given on a 5-point scale (1 = very good, 5 = poor). The answers were 
compared to those obtained in 1991-1992 from a Dutch population of the 
same age (CBS 1993). The COOP/WONCA6 was also used as a generic 
measure of quality of life. This instrument converts issues such as physical 
fitness, feelings, daily activities, social activities, pain, change in health and 
general health. The state of health for these issues could be marked on a 5-
point scale (one for each question). Figure 1 shows the COOP/WONCA pain 
chart. A total of seven questions were used to gain an impression of the 
functional status of each patient over the preceding two-week period. This 
was defined as the ability of a person to perform in and adapt to his/her 
environment. 
The Cancer Rehabilitation Evaluation System - Short Form, CARES-SF 
(Dutch translation) was used to develop our own disease-specific measure-
ment instrument. The adapted version comprised three scales and a number 
of separate items; specific questions about breast cancer, prostate cancer or 
intestinal cancer were omitted. The scales inquired about physical condition 
(8 items), psychosocial condition (13 questions) and several relational 
aspects. There were separate items about the adequacy of the information 
provided by the doctors, financial problems, insurance problems and 
transport difficulties. A total of 30 items were presented on the questionnai-
re. The question asked whether a specific problem had been applicable to the 
respondent during the preceding four-week period. Answers could be given 
on a 5-point scale (0 = not at all, 4 = very much). 
The physical condition of the patient as a result of cerebello-pontine angle 
surgery was determined on the basis of the surgical effects on: hearing (as 
experienced by the patient with both ears), tinnitus, vertigo and facial nerve 
function. Hearing was measured by asking whether it had been adequate 
(good) or inadequate (poor) preoperatively and whether it had improved, 
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remained the same, or deteriorated after the operation. Facial nerve function 
was measured as a percentage. There were six categories from 0% to and 
including 100%, in steps of 20%. This six-step scale was in some degree 
similar to the House-Brackmann scale with six grades8; 100% and 0% were 
equivalent to House Grades I and VI, respectively. The patients were also 
asked whether they had been using a hearing aid, or had ever received 
treatment to improve facial nerve function; in addition, they were asked to 
give their own opinion of whether recovery was complete (100%) or partial 
(at least 50%) and how long this had taken. 
Use of medical facilities was measured by means of questions from the CBS 
about the number of visits to the GP, specialist, physiotherapist, homoeopa-
thist and admission(s) to hospital. The outcomes were compared to average 
values for the use of medical facilities in the Netherlands. 
PAIN 
During the past 4 weeks ... 
How much bodily pain have you 
generally had? 
No pain 
Very mild pain 
Mild pain 
Moderate pain 
Severe pain 
ê 
fà "* 
/3& ^ 
fb ^ 
•сэ li 
Figure 1: 
Example of a COOP/WONCA pain chart 
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On each questionnaire that was returned to us, the treating physician 
recorded the operation date, surgical approach, tumor size, number of 
reoperations and postoperative facial nerve function (if possible one year 
after the operation). 
The questionnaires were analysed anonymously. Not all the patients had 
answered all the questions. In the results we mention how many had 
answered a particular item. The outcomes were indexed to patient data such 
as age and sex. 
Two surgical approaches were distinguished: translabyrinthine/transotic and 
suboccipital. Tumor size was defined as the maximum diameter, including 
the intrameatal part. Contrast was made between small tumors (< 25 mm) 
and larger tumors. 
The EPI-INFO computer programme was used for data input. Statistical 
analyses were performed with SPSS/PC +, the chi square test and a variation 
analysis. As the maximum follow-up period of the patients was 14 years, the 
operation date was incorporated as a covariable9. In this way, the effects 
were corrected for the length of the postoperative period and we also 
compensated as much as possible for whether the operation had taken place 
many years ago or recently. 
An important condition for such an analysis is to ensure that the so-called 
parallel assumption is not violated. We fulfilled this condition. The results 
are presented in a simple manner: the corrected means are given without 
mentioning any data related to the parallel assumption and the size of the 
covariable. Ρ values are given for significant differences. In the analyses, 
especially the effects of the surgical approach and tumor size were evaluated. 
Distinction was made between patients who had undergone one operation and 
those who had undergone reoperation(s). 
RESULTS 
The questionnaire was sent to 174 patients. A total of 40 questionnaires 
could not be used in the analyses because the patient had moved house and 
was untraceable (N = 14), or the patient had refused to participate (N = 17) or 
had died (N = 9). The response rate in the total group was 89% (134/151); 
88% (79/90) in the suboccipital approach group and 90% (51/61) in the 
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translabyrinthine/transotic approach group. The study population comprised 
68 men and 64 women with an average age of 53.95 years (SD=14.45) at 
the time the survey was conducted. The difference in age between the men 
and the women was not significant. There was no significant difference 
between the sexes, ages and approaches in relation to a certain tumor size 
and whether or not reoperations had been necessary. Table 1 shows the 
distribution of the patients according the approach and tumor size. 
The patients with a translabyrinthine/transotic approach and a tumor diameter 
of larger than 25 mm were excluded from the analyses (incorporating 
approach and tumor size) because of low numbers (N=3). In 17 patients, 
reoperation^) had been necessary owing to recurrence after subtotal or near 
total removal. These operations were mainly conducted after a suboccipital 
approach with a tumor diameter of larger than 25 mm. The reason for this 
was the large number of subtotal suboccipital operations performed at our 
clinic4. 
Table 1: 
Patients: approach, tumor size and re-operations (N=134) 
number of operations translab/otic translab/otic Suboccipital Suboccipital 
approach, approach approach approach 
tumor ¿ 25mm tumor > 25mm tumor size <. 25mm tumor size 
> 25mm 
1 
operation 
more than 
1 
operation 
total no. 
of patients 
51/134 
38% 
1/134 
1% . 
52/134 
39% 
2/134 
1% 
1/134 
1% 
3/134 
2% 
21/134 
16% 
1/134 
1% 
23/134 
17% 
43/134 
32% 
14/134 
10% 
57/134 
42% 
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Analyses on the effect of whether or not reoperation(s) had been necessary 
were only performed on the group with a suboccipital approach and a large 
tumor because of the low number of patients with reoperations in the other 
groups. Table 1 also shows how many patients underwent reoperation(s) per 
approach and tumor size-General state of health 
In answer to the CBS question on the general state of health, the patients 
with reoperations (M=2.27) reported better health than those who had only 
undergone one operation (M=2.82), F(l,54) = 4.54, Ρ < 0.04. It was not 
possible to explain this unexpected effect. There was no significant 
difference between the surgical approaches. 
All the data on the patients with acoustic neuroma surgery were compared to 
the CBS data for a Dutch population (of comparable age): the state of health 
of the patients was considerably poorer than that of the population mathed 
for age (see Figure 2). 
well acceptable poor bad 
health condition 
• acoustic neuroma pt Ш CBS 
Figure 2: 
General state of health of the patients after surgery for an unilateral acoustic 
neuroma compared to data from the CBS 
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The answers given by the patients with and without reoperations for three of 
the seven COOP/WONCA questions (pain, general health and feelings) were 
significantly different. Patients with reoperations (M = 1.80) reported 
significantly less severe pain than the patients without reoperations (M=2.7-
5), F(l,50) = 5.07, Ρ < 0.03. Patients with reoperations (M=2.05) 
reported better general health than the patients without reoperations 
(M = 1.57), F(l,50) = 3.24, Ρ < 0.08. It would be obvious to ascribe this 
unexpected effect to the difference in the level of pain experienced by the 
patients with and without reoperations. As the level of pain decreased, the 
state of general health increased. The COOP/WONCA answers showed that 
the patients with a suboccipital approach - irrespective of the diameter of the 
tumor (M=2.3 small tumor; M =2.37 larger tumor) had more emotional 
problems than the patients with a translabyrinthine/transotic approach 
(M = 1.80, F(2,98) = 2.37, Ρ < 0.10. The disease-specific measure for the 
quality of life (the CARES-SF) comprised three scales. These scales were 
found to be reliable in this study. Chronbach's alpha was 0.83 for the 
physical scale, 0.81 for the psychosocial scale and 0.75 for the relational 
scale. The answers to the CARES-SF showed very little difference between 
patients with or without reoperations and/or between the surgical approaches 
and tumor diameters. Only the psychosocial scale revealed a difference 
between patients with and without reoperations F(13,40) = 1.95, Ρ < 0.06. 
The difference was mainly based on two items: "finding it difficult to sleep" 
F(2,52) = 5.09, Ρ < 0.03 and "worrying about becoming dependant on 
others in the future" F(2,52) = 4.48, Ρ < 0.01. When the patients with 
reoperations were compared to those without reoperations, the former had 
less difficulty with sleeping (M = 1.15 versus M=0.35) but were more 
worried about the time that they would no longer be able to look after 
themselves (M=0.99 versus M = 1.76). On an item level, one more effect 
could be seen. Irrespective of the tumor diameter (M=0.74 small tumor; 
M =0.72 larger tumor) more of the patients with a suboccipital approach 
complained of pain than the patients with a translabyrinthine/transotic 
approach (M=0.37), F(2,lll)=2.46, Ρ < 0.10. It was concluded that there 
was more pain after a suboccipital approach (CARES-SF) but that it was less 
severe (COOP/WONCA) than after a translabyrinthine/transotic approach. 
The CARES-SF items could be expressed as one collective quality of life 
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measure. This measure comprised the sum of all the answers given. No 
significant differences were found between the patients with and without 
reoperations or between the two approaches for a certain tumor diameter. 
The quality of life of the patients was influenced to a limited extent (some 
questions on the CARES-SF) by the surgical approach and whether or not 
reoperation(s) had been necessary. 
A high level of satisfaction (93%) was expressed about the preoperative 
information and counselling provided by the doctors and nurses. 
Influence of the operation(s) on home help 
A total of 41/130 patients (32%) required home help after the operation(s); 
36 only required help with housekeeping tasks. Two patients needed medical 
care and help with their personal care. All three forms of help were required 
by one patient. The help was provided for payment by third parties (45%), 
by members of the family (44%), or by a combination of the two, sometimes 
with other relatives or neighbours (11%). Receiving help was not related to 
the age of the patient. 
Employment 
A distinction was made between paid work and unpaid work. We asked 
about the situations three months before the operation and one year 
afterwards. Preoperatively, 59/134 patients (44%) had paid employment; 
75/134 patients (56%) had unpaid work. One year after the operation, 
49/134 patients (37%) had paid work and 85/134 (63%) had unpaid work. 
At one year post-operation, (un)paid work had been resumed fully by 54% 
and partly by 15%; 31% were no longer able to work (N=94). About 10% 
of the patients had found alternative employment (N=94). In the Nether­
lands, it is possible for long-term patients to be given leave of absence from 
work during the evaluation period while retaining (partial) pay. Of the 119 
patients who answered this question, 31 patients (26%) were declared unfit 
to work according to these norms. The number of patients with a large tumor 
in this group was significantly higher than the number with a small tumor 
(X2(l) = 9.15, Ρ <0.005). Suboccipital surgery led significantly more often 
to being declared unfit to work than translabyrinthine/transotic surgery 
(X2,(l)=5.96, p<0.05). The main reasons were vertigo and hearing 
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impairment. 
Table 2: 
Overall preoperative and postoperative hearing (hearing with 2 ears, patients' 
view) (N = 128) 
overall hearing after surgery hearing preoperative hearing preoperative 
poor good 
N = 
hearing improved 
hearing unchanged 
hearing deteriorated 
119 
1/119 
1% 
70/119 
59% 
48/119 
40% 
9 
0/9 
8/9 
(89%) 
1/9 
(11%) 
Table 3: 
Preoperative and postoperative complaints of tinnitus (N = 106) 
tinnitus after surgery tinnitus preoperative no tinnitus preoperative 
N = 
tinnitus improved 
tinnitus unchanged 
tinnitus deteriorated 
81 
20/81 
(25%) 
32/81 
(40%) 
29/81 
(35%) 
25 
1/25 
(4%) 
18/25 
(72%) 
6/25 
(24%) 
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Income 
Only 67/134 patients (50%) provided information about their income. The 
income of 24/67 patients changed and in 21/67 it decreased as a result of the 
operations. Two patients who were self-employed encountered financial 
problems after the operation. 
Physical health in relation to hearing, tinnitus, vertigo and facial nerve 
function 
The surgical approach, tumor size and reoperation(s) did not have any 
influence on hearing (Table 2) and tinnitus (Table 3); in the further analyses 
we did not distinguish between them. A remarkably large proportion of the 
patients without vertigo preoperatively (Table 4, N=23) had vertigo 
complaints after translabyrinthine/transotic surgery. Some of the patients 
with vertigo before the operation (Table 5, N=63) mentioned improvement 
after suboccipital surgery. Only five patients (4%) needed a hearing aid, 
while 99 patients (81%) had not needed a hearing aid before the operation or 
afterwards. 
Table 4: 
Preoperative (N=23) versus postoperative results of patients without vertigo 
approach and tumor size/ translab/otic suboccipital suboccipital 
postoperative results tumor size <_ 25 mm tumor size _< 25 mm tumor size > 25 mm 
N = 
no vertigo postoperative 
vertigo postoperative 
10 
4/10 
(40%) 
6/10 
(60%) 
5 
4/5 
(80%) 
1/5 
(20%) 
8 
5/8 
(62%) 
3/8 
(38%) 
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Table 5: 
Preoperative (N=63) versus postoperative results of patients with vertigo 
approach and size/ translab/otic suboccipital suboccipital 
postoperative results tumor size _< 25 mm <_ 25 mm > 25 mm 
vertigo improved 
fewer complaints 6/21 3/10 15/32 
(29%) (30%) (47%) 
vertigo unchanged or deteriorated, 
more complaints 15/21 7/10 17/32 
(71%) (70%) (53%) 
Facial nerve function 
We asked about the level of facial nerve function (patient's and treating 
physician's opinion), whether there were facial nerve problems before 
surgery and whether adjuvant treatment was necessary after the operation. 
The patients' opinions about postoperative facial nerve function was 
influence significantly by reoperations (F(l,44)=3.11, P<0.09), but not by 
the surgical approach or the tumor size. Patients with reoperation(s) 
(M=3.91) reported considerably poorer facial nerve function than the 
patients with only one operation (M=2.80). 
When the same evaluation was made by the treating physician, it was found 
to be influenced significantly by the surgical approach and tumor size 
(F(2,lll)=3.70, P<0.03), but not by whether or not the patient had 
undergone reoperations. The most favourable facial nerve function was 
mentioned after a translabyrinthine/transotic approach for a small tumor and 
the poorest function after suboccipital surgery for a larger tumor (M=2.38). 
Intermediate results were reported after suboccipital surgery for a small 
tumor (M = 1.87). Figure 3 shows facial nerve function in House-Brackmann 
Grades (one year postoperatively, N=123) against the percentages given by 
the patients (describing their present condition). 
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1/100% 2/80% 3/60% 4/40% 5/20% 6/0% 
House grade / percentage of facial function 
Figure 3: 
Evaluation of facial nerve function by the patient in percentages (100%-0%) 
and the treating physicians (House Grades І- Г) 
Table 6: 
Patient's view of facial nerve function (N=123) 
preoperative (some) facial paresis 
(N=21) 
preoperative normal facial nervefunction 
(N = 105) 
translab/otic suboccipital suboccipital 
tumor size tumor size tumor size 
£ 25 mm < 25 mm > 25 mm 
translab/otic suboccipital suboccipital 
tumor size tumor size tumor size 
S 25 mm S 25 mm > 25 mm 
N N=4 N=4 N = 13 N=48 N = 17 N=40 
postoperative 
(some) facial 
paresis 
postoperative 
normal facial 
nerve function 
5 (1) 
4 4 8 (2) 
In parenthesis: number of patients with reoperations 
13 6 (1) 21 (8) 
35 (1) 11 19 (3) 
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Figure 4: 
Duration and level of recovery per approach and tumor size; partial recovery 
(at least 50%) and full recovery (100%) with the percentage of patients. 
The difference in evaluations between the doctor and the patients deviated in 
accordance with the correlation measure. There was only slight correlation 
between them: r=0.67, P<0.001. Particularly answers of 0% and 100% 
(the extremes) were responsible for the difference: 56.7% had 100% 
function according to the doctor versus 44.3% according to the patients; 
5.2% had 0% function according to the doctor versus 12.2% according to 
the patients. There was reasonable agreement on the other scales. 
Recovery 
We enquired about the level of recovery and the time that had elapsed. 
Partial recovery was mentioned by 92/97 patients within one year of the 
operation (at least 50% recovery); 56/97 had recovered fully in this time. 
Full recovery had taken longer than one year in 10/97 patients, while 31/97 
patients had not yet recovered fully. Surgical approach for a particular tumor 
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size and whether or not there had been reoperations did not have any 
significant effects on recovery (Figure 4). Adjuvant treatment was necessary 
in 45/134 patients (34%). It mainly comprised physiotherapy (60%), plastic 
surgery (7%), surgical reconstruction of the facial nerve (4%) or a combina­
tion of the three (20%). 
Use of medical facilities 
The use of medical facilities was higher in the patients with acoustic 
neuroma surgery than in the general Dutch population. During the past year, 
85.3% of the patients had visited their GP versus 75.5% of the general 
Dutch population in 1991/1992 (of comparable age). These percentages for 
specialist consultations were 82.6% and 39.8%, respectively; for admissions 
to hospital: 20.7% and 6.9%, respectively. Rates for physiotherapy and 
homeopathy reported by the patients were twice as high and one and a half 
times as high as those of the general Dutch population, respectively. No 
significant differences were found in the patient group for surgical approach 
for a particular tumor size and whether or not there had been reoperations. 
There was a difference in the number of times the GP had been consulted in 
the previous two months. Irrespective of the tumor size, the GP had been 
visited significantly more often (F(2,111)=4.79, Ρ<0.02) after a suboccipi­
tal approach (M = l.l l small tumor; M = 1.24 larger tumor) than after a 
translabyrinthine/transotic approach (M=0.47). 
DISCUSSION 
Very little research has been performed on the quality of life of patients after 
having undergone surgery on the cerebello-pontine angle for the treatment of 
an acoustic neuroma. The best known study was published by the Acoustic 
Neuroma Association2 after the members of this patient association had been 
sent a questionnaire. The study group comprised patients who had encounte­
red different treating physicians and had been operated on via various 
approaches at diverse centres. The study by Parving2 from Copenhagen was 
conducted exclusively on patients who had undergone translabyrinthine 
surgery; the tumor size and reoperations were not included in the analyses. 
Aspects such as the postoperative hearing level were described, although 
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generally, only the changes in hearing in the operated ear received conside-
ration. In this study we evaluated the effects that the surgical approach, 
tumor size and reoperations had had on the quality of life and on the views 
of the patients. 
The quality of life was closely correlated with the general state of health. 
After cerebello-pontine angle surgery, the state of health was poorer than 
that in comparable groups of patients, as was shown by both the generic and 
disease-specific measurement instruments. It was remarkable that the state of 
health of the patients with reoperations was better than expected. These 
patients reported less pain and slept better than average. Concerns about the 
future, on the contrary, increased if the patient had undergone reoperations. 
The surgical approach had an influence on pain; the translabyrinthi 
ne/transotic approach was associated with less pain, but it was more severe 
than the pain after suboccipital surgery. We could not find a reasonable 
explanation for this. After discharge from hospital, the operation affected the 
situation at home; one third of the patients required home help. The 
operation had less effect on a patient's income, but over 25% of the patients 
were declared unfit to work. These mainly comprised patients who had 
undergone suboccipital surgery for a larger tumor. 
Recovery after the operation was a long-term process and full recovery was 
not always achieved. The long recovery period and problems with resuming 
work were also mentioned in the report on members of the Acoustic 
Neuroma Association2. 
Our questions about hearing concerned bilateral hearing, with a good ear and 
a poor or deaf ear. According to the majority of patients, hearing (Table 3) 
was already poor before the operation (92%). This did not improve in the 
postoperative period, or it deteriorated further. Even adequate hearing was 
seldom spared by surgery. It was not always necessary or worthwhile to use 
a hearing aid for postoperative hearing impairment if only one ear was 
affected. 
Preoperative tinnitus complaints did not often improve after surgery (25), but 
they could develop (24%) or remain unchanged (40%). This is contrary to 
the findings of Berlinger et al.10 who reported that surgery more often 
improved the complaints (37%) than caused them to deteriorate (15%) and 
that postoperative tinnitus developed in 34%. 
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Before the operation, 63/86 of our patients had vertigo. Surgery had various 
effects. With small tumors, the complaints sometimes improved, but they 
more often deteriorated. With large tumors (suboccipital approach) the 
complaints generally improved postoperatively. This may have been due to a 
reduction in cerebral pressure after the tumor has been removed. It was 
remarkable that some of the patients who did not have vertigo preoperative-
ly, developed complaints after translabyrinthine/transotic surgery (Table 4). 
This might have been cause by the removal of an as yet unaffected labyrinth 
during the operation. However, the numbers were very small. 
According to the treating physician, postoperative facial nerve function was 
poorer after surgery for large tumors and after reoperations. The answers the 
patients gave on the questionnaires showed that this was not significant. This 
is remarkable because the classifications of the patients and doctors were in 
reasonable agreement, except at the extremes (Figure 3). The latter was 
responsible for the final outcome of poor correlation. It is possible that 
paresis symptoms of the trigeminal nerve also played a role, because patients 
often attribute the sensitivity of the face to facial nerve function. 
The patients made considerable use of medical facilities. The GP and 
specialist were visited more often, as were the physiotherapist and homoeo-
pathist. There were more admissions to hospital in this patient group. The 
larger number of visits to the GP by patients after suboccipital surgery may 
have been the result of poor facial nerve function and the associated eye 
problems. 
CONCLUSION 
Cerebello-pontine angle surgery had a great deal of influence on the quality 
of life of the patients. The postoperative recovery period was long and 
recovery was not always full. Patients had a poorer general state of health 
and made more frequent use of medical facilities. A large proportion of the 
patients reported problems with their social life and work, but seldom with 
their income. Preoperative symptoms such as hearing loss, vertigo and 
tinnitus, were influenced by the operation. Facial nerve function often 
deteriorated postoperatively and sometimes reconstructive surgery was 
necessary. 
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The surgical approach affected the postoperative quality of life. Facial nerve 
function was better in the patients with translabyrinthine/transotic surgery. 
This approach led to less pain, but when present, it was more severe. Fewer 
patients were declared unfit to work and there were fewer visits to the GP 
than after suboccipital surgery. Reoperations after subtotal removal using the 
suboccipital approach had less influence than expected. The general state of 
health had even improved in some cases, but there were more emotional 
problems and concerns about the future. Facial nerve function deteriorated 
after reoperations. Larger tumors were more often associated with being 
declared unfit to work and reoperations than small tumors. 
Adequate patient education should be based on surgical results and also 
consider patients' postoperative experience and opinions. For small tumors, 
the translabyrinthine/transotic approach seems to be preferable to the 
suboccipital approach. Despite good surgical results and a decreasing number 
of complications, there is still considerable morbidity and prolonged 
recovery. It is important to realise this and to prepare (new) patients for 
these eventualities. 
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CHAPTER Vila 
Unchanged unilateral hearing loss and ipsilateral growth 
of an acoustic neuroma from 1 to 4 cm 
ABSTRACT 
Progressive sensorineural hearing loss is the most important early symptom 
of a cerebellopontine angle process. A case report is presented of a 42-year-
old woman who was referred to our department in 1979. Oil cisternography 
showed non filling of the left internal acoustic canal. Audiometry was 
planned as the method of control, but she did not return until nine years 
later. In 1988, an acoustic neuroma of 4 cm diameter was found in the left 
CPA. Pure tone audiometry and speech audiometry showed that during the 
nine-year interval, her 60 dB flat sensorineural hearing loss and speech 
perception threshold had remained almost unchanged. A follow-up with only 
tone and speech audiometry can lead to a false negative diagnosis in some of 
these cases. Calculation of the growth in tumour volume over nine years in 
this patient showed a tumour volume doubling time of about 15 months. 
CASE REPORT 
In 1979, a 42-year-old woman was seen at the Nijmegen Institute of ORL. 
She had a three-year history of unilateral progressive sensorineural hearing 
loss and tinnitus, without vertigo. She had been suffering from headaches 
diagnosed as migraine. Her otoscopy results were normal. Pure tone 
audiometry showed a 60 dB unilateral sensorineural hearing loss and her 
speech perception was 45% at 100 dB (Fig. 1). Stapedial reflexes elicited 
contralateral^ in the left ear, showed a pathological decay at 0.5 and 1.0 
kHz and were absent at 2 and 4 kHz. Electro-cochleography combined with 
brainstem evoked response audiometry showed a pathological interwave 
delay for J1-J5. Electro-nystagmography showed non-pathological position 
nystagmus. Caloric results were normal on both sides. Oil cisternography 
showed no filling of the left internal acoustic canal (Fig. 2). A small 
intracanalicular tumour or an artefact was suspected. It was therefore decided 
to perform tone and speech audiometrie control investigations at six-monthly 
intervals and to repeat the oil cisternography after six months, making use of 
the original oil in the thecal sac. 
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Figure 1: 
Tone and speech audiogram at the age of 42 years 
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Figure 2: 
Oil cisternography (duroliopaque) of the left CPA at the age of 42 years 
showing non-filling of the left CPA. 
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Figure 3: 
Axial (A) and coronal (B) CT slice with IV contrast of the left CPA showing 
an acoustic neuroma with a diameter of 4 cm. 
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Figure 4: 
Tone and speech audiogram preoperatively at the age of 51 years 
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A six-month follw-up appointment was planned at the ENT Department, but 
the patient did not return. After a delay of nine years, the by then 51-year-
old woman was seen at the Department of Neurology with additional 
complaints of intense and progressive headaches with nausea and vomiting 
and increasing vertigo. A cranial CT scan with intravenous contrast showed 
a space occupying lesion in the left CPA with a diameter of 4 cm (Fig. 3). 
The results of repeated pure tone and speech audiometry were very similar to 
the original results (Fig. 4). Brainstem evoked response audiometry of the 
left ear did not yield a discernible pattern, therefore this was indicative of 
serious disturbance. Electro-nystagmography now revealed a lack of caloric 
response in the left ear, whereas fundoscopy of the eyes was normal. 
Neurological examination of the cranial nerves showed a loss of skin 
innervation of the region of the left platysma, while the facial nerve 
functions were normal. She was unable to walk in a straight line. 
The tumour was only partially removed using the suboccipital approach. 
Histological examination demonstrated an acoustic schwannoma. She made a 
good postoperative recovery, her facial function was normal, the vertigo had 
disappeared, but complaints of migrainous headaches remained. Postoperati-
ve CT-scans of the left CPA region showed a residual tumour with a 
diameter of 2.5 cm. A CT scan performed three years later showed no 
growth. 
An estimation can be made of the tumour volume growth rate in this 
documented case. During nine years of growth, an intrameatal process 
resulted in a 4 cm diameter tumour. The radius increased from 0.5 to 2.0 
cm. In case of volume calculation the neuroradiologist should describe the 
shape of the tumour with the several diameters. This shape was somewhere 
between a cilinder and a sphere. This resulted in a 1979 tumour volume of 
0.4 and 0.5 cm3 and a 1988 tumour volume of 25 and 33 cm3. The doubling 
time was calculated as being about 15 months (Fig. 5). If the tumour growth 
were linear, the length would increase by about 0.33 cm/year. This growth 
lies between the slow (0.2 cm/year) and fast (1.0 cm/year) growth rates of 
tumours according to Silverstein et al (1985). The dormant situation of the 
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remaining tumour after surgery has also been reported in one of the cases 
studied by Wazen et α/.(1985). 
DISCUSSION 
In the past, we had proposed performing audiological screening at six-
monthly intervals over a period of three years for patients whose examination 
results (extensive otoneurological examination, brainstem audiometry and air 
CT cisternography) were not conclusive of a very small acoustic neuroma or 
other space occupying lesion in the internal auditory canal (Musiek et al., 
1983; Cremers, 1984). Additional neuroradiological examination could also 
be performed if the sensorineural hearing loss increased or other symptoms 
arose. This was our policy for more than ten years and was based on the 
limited availability of neuroradiological facilities and considerations 
regarding cost and efficacy. 
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Figure 5: 
The tumor volume in the case of a cylinder is 7rr2L and of a sphere 4/3 жъ. 
The 1979 diameter was 10 mm and the 1988 diameter was 40 mm. The 
calculated volume in 1979 was about 0.4-0.5 cm3 and in 1988 about 25-33 
cm
3
. Assuming linear growth, the tumor doubled at least seven times every 
15 months. 
114 Unchanged unilateral hearing loss 
This case report illustrates that audiological screening with tone and speech 
audiometry does not always provide a sufficient means to detect a growing 
tumour. Recently, MRI facilities have become available and a patient who 
shows no filling of the left internal acoustic canal during oil cisternography, 
would be a good candidate for MRI of the left CPA. Although audiometrie 
follow-up does not usually present any difficulties and is not time-comsuming 
or expensive, it now appears necessary to carry out MRI in addition. 
The growth rate of acoustic neuromas is not well-documented. Reports in the 
literature are sparse and they mostly deal with experimental situations 
(Nedzelski et al, 1986) or CPA processes in elderly people (Wazen et al, 
1985; Thomsen and Tos, 1990). Tumours are measured radiologically or 
per-operatively and there is no standardization of the measurement methods. 
Documented cases can contribute to a more detailed knowledge of tumour 
growth rates. Standardization of the methods for measuring tumours, as for 
example has been suggested by Nedzelski et al. (1986) is necessary and 
calculation of the volume may be preferred in all cases. 
More detailed knowledge on tumour growth rates can possibly support and 
account for a period of careful observation and waiting in elderly people 
with tumours (Thomsen and Tos, 1990). 
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Bilateral malignant hemangiopericytoma of the internal acoustic canal 
ABSTRACT 
A case report of a twenty year old female with a bilateral malignant 
hemangiopericytoma in the cerebellopontine angle (CPA) is presented. 
Several diagnoses were rendered. The initial complaints were pareses of the 
left leg and right hand. The first diagnosis was multiple sclerosis, but an 
intramedullary tumor was found and operated on. Later an unilateral 
deafness of the right ear occurred. A tumor was seen in both the cerebello­
pontine angles, and the diagnosis neurofibromatosis type Π was rendered. 
The tumor on the right side was near totally removed by the translabyrinthine 
approach. Nevertheless both CPA tumors continue to grow, and metastases 
were found later over the cerebrum. The final diagnosis is a bilateral 
malignant hemangipericytoma, which has not been described in the CPA. 
Pathological examination of CPA lesions may be usefull in doubtfull cases, 
where a "wait and see " policy is considered. 
CASE REPORT 
In 1968 a twenty year old woman visited the department of neurology with 
complaints of decreasing strength in the left leg, and less strength and 
rigidity in the right hand. At first the diagnosis multiple sclerosis was 
considered. Neurological examination showed a Brown Sequard syndrome. 
The myelogram with intrathecal contrast showed a total stop at the 7th 
cervical vertebra. A neurosurgical laminectomy was performed and the 
arches of the cervical vertebrales 4, 5 and 6 were removed. A tumor with a 
size of 4 cm was removed, with very difficult hemostasis afterwards. The 
postoperative recovery was without complications, and the symptoms 
disappeared. The first pathological diagnosis was most likely a neurofibroma. 
The diagnosis neurofibromatosis II was rendered because the patient also had 
a café-au-lait skin lesion and a typical 3th and 4th square vertebra. 
In 1986 the patient was seen with the same complaints of progressive paresis 
in the right arm and the left leg. There were also pain symptoms in the neck 
region. Untili 1986 all prior symptoms had completely disappeared. 
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Neurological examination indicated compression of the myelum. The pupils 
of the eyes were not symmetrical. Myelography with intrathecal contrast 
showed a space occupying lesion at the 6th cervical vertebra. After radical 
surgical intervention the tumor was removed. The pathological diagnosis was 
most likely either a malignant hemangiopericytoma or a malignant nerve 
sheet tumor. Postoperative irradiation followed with a 46 Gy dosis, and the 
patient fully recovered. 
In 1991 the patient visited the department of otolaryngology with a right-
sided unilateral hearing loss. Audiological examination showed a deaf right 
ear and normal hearing on the left side. The acoustic brainstem audiometry 
gave no signal on the right side, but unexpectately a large interwave delay of 
J1-J5 was found on the left side. CT-scanning with intravenous contrast 
showed a tumor of 1 cm on both sides (Fig. 1). 
Figure 1: 
CT-scan with contrast in 1991 with a bilateral tumor in the CPA 
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The deaf right ear was operated by the translabyrinthine approach. Central 
neurofibromatosis type II was again supposed to be the origin. Tumor 
removal was performed to prevent brainstem compression in the near 
future.The tumor showed ingrowth into the facial nerve, and therefore only a 
near total removal was performed, to maintain the facial nerve function. The 
pathological examination resulted in the diagnosis hemangiopericytoma. The 
patient had a follow up with multiple MRI-scans (fig 2). The tumor and 
tumor-rest in the cerebellopontine angles were both growing and an 
irradiation of the temporal regions was done. Nevertheless the tumor gave 
multiple metastases in the brain. In 1994 a new attempt to decompress the 
skull contents was done, but only temporarely succesfull. The patient needed 
a wheel chair, was rapidly deteriorating and died in 1994 as a result of brain 
edema. 
Figure 2: 
MRI with Gadolinium in 1994 with two metastases 
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PATHOLOGY 
The microscopy of the intradural, intra- and extramedullar tumors removed 
in 1968, 1986 and 1994, and of the CPA tumor removed in 1991 was 
simular. The small to medium sized, polygonal or rounded tumor cells were 
lying in highly cellular sheets. The cells were individually and in small 
groups surrounded by reticulin fibers (Fig 3). The cells contained some 
amphophilic cytoplasm. The round to oval nuclei showed moderate 
polymorfism and inconspicuous nucleoli. Occasional mitoses and small foci 
of necrosis were present. The tumor showed dispersed, slit like vascular 
spaces. Only sporadically "staghorn" vessels were found. Whorl formation 
and spindle cells were absent. 
Figure 3: 
Higly cellular tumor tissue removed in 1991. Note that the tumor cells are 
individually and in small groups surrounded by reticulin fibers (Laquesse 
staining, original magnification x200) 
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Immunohistochemically, the tumor cells were strongly positive for vimentin, 
sporadically positive for cytokeratin, and negative or equivocally staining for 
S100, muscle actin, and epithelial membrane antigen (EMA). Electron 
microscopical investigation of the tumor removed in 1994 revealed some 
rudimentary intercellular junctions and an extensive presence of electron-
dense, basal lamina like material in between the tumor cells. Well-formed 
desmosomes and complex interdigitations of cell membranes were absent. 
Revision of the tumor removed in 1968 revealed tumor tissue of moderate 
cellularity with elongated or spindle shaped cells lying in myxoid stroma. 
However, some parts of this tumor showed hypercellular areas with a picture 
as described above. 
DISCUSSION 
Neurofibromatosis II is the most common cause of bilateral schwannoma in 
the CPA. A malignant hemangiopericytoma is not described before in both 
angles by the authors knowledge. The different diagnosis of this patient 
included at first multiple sclerosis, neurofibromatosis II, a malignant nerve 
sheet tumor and finally a malignant hemangiopericytoma. Hemangiopericyto-
ma are vascular neoplasms that can metastasize to several organ systems. In 
a study of Mena1 94 cases were discussed. Most of these tumors growed 
superficially and adherent to the meninges. Radley2 mentioned nine cases of 
meningeal hemangipericytoma in the spine and cerebrum. Nevertheless it is a 
rare tumor, and the malignant variant is seldom found. After revision of the 
tumor slides of 1968, 1986, 1991 and 1994 the lesions in this patient 
appeared to be a malignant hemangiopericytoma in all four cases. 
The clinical history caused the first confusion with neurofibromatosis II. 
Afterwards it was difficult to differentiate between either a malignant nerve-
sheat tumor or a heamangiopericytoma. The increasing number of tumors 
that are detected nowadays using MRI includes the rise of considering a rare 
tumor as an acoustic neuroma or menigeoma. The prognosis of the lesions 
may be very different (Seppala3). The first publications of false positive MRI 
scans are published (Barbara4, Donnely5). The nowadays sometimes proposed 
"wait and see" policy for small tumors of the CPA tumors (Cox6) bares the 
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rise of following a malignant and metastasizing tumor. The incidence of 
these aggressive tumors fortunately is low, but a non-treated patient should 
be informed if there is no certainty about the histology of the tumor. 
CONCLUSION 
The diagnosis of a space occupying lesion in the CPA is difficult, because 
the varying symptoms. In most cases it will be an acoustic neuroma or a 
meningeoma (Brackmann7). If lesions in both angles are found the diagnosis 
often will be neurofibromatosis II. In rare cases an other bilateral tumor is 
found as a metastasizing bilateral malignant hemangiopericytoma. A 
multidisciplinairy approach may lead to a correct diagnosis, and the history 
may be helpfull but also confusing. In case of a presumed neurofibromatosis 
type II the diagnosis may be confirmed by a gene diagnosis. It is advised to 
consider a biopsy in doubtfull cases, and to consult an expert in pathology 
for the final diagnosis. A "wait and see" policy for tumors of the CPA 
includes some rises. 
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CHAPTER Vile 
Unilateral hearing loss due to a rhabdomyoma in a six year old child 
ABSTRACT 
Unilateral sensorineural hearing loss and complete unilateral deafness seems 
to occur in 1 out of 1000 children at school age'. The cause most often 
remains unknown. Rarely a genetic origin can be traced2. In adolescents and 
adults a small asymmetric sensorineural hearing loss already requires an 
investigation of the cerebello-pontine angle to exclude a space-occupying 
lesion. A case report is presented of a six year old boy with an unilateral 
sensorineural hearing loss. After histological studies it appears to be a 
rhabdomyoma, which previously has been reported only once in a intracrani-
al location in the trigeminal nerve3. Nowadays we have an easy access to 
advanced imaging techniques of the inner ear and the cerebello-pontine 
angle. Modern radiology is non-expensive and comfortable for patients. 
These additional investigations should be considered using also at children's 
age. 
CASE REPORT 
In 1990 a six year old child was referred to the ORL department of the 
University Hospital Nijmegen because of a unilateral hearing loss, found at a 
regular screening at school. There was no medical history. In a scheduled 
examination after the first year of life a hearing loss had been noticed, but 
no further action had taken place. The speech and motoric development were 
normal. Only running fast was never possible in comparison with school 
mates. At the ENT-examination a normal eardrum was seen, with an air 
containing middle ear. The tuning fork test according to Rinne and Weber 
were said to be normal, and the Barany noise box test proved that both ears 
could hear. At pure tone audiometry a sensorineural hearing loss was found 
with a Fletcher Index of 50 dB at the left ear. Speech audiometry gave a 
word discrimination of 100% with the same 50 dB shift. At the right ear the 
hearing was normal. Contralateral stapedial reflexes could be eliced at both 
sides. The ABR at the left side revealed a interwave delay from J1-J3 and 
J1-J5. Also on the right side a much smaller interwave delay J1-J5 was 
found. Labyrinth testing with calorisation indicated a reduced function of the 
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left labyrinth. MRI scanning had just become available in a nearby hospital 
and a tumor of the eight nerve was found (figure 1). It was not possible to 
use Gadolinium' because the child did not cooperate at that moment. Later a 
CT scan with the use of contrast showed a tumor of 17 mm in the left 
cerebello-pontine angle (figure 2). Angiografy showed no abnormal vascular 
structures. The patient was referred to the neurosurgical department, and a 
suboccipital approach was used for the exploration of the cerebello-pontine 
angle. During the operation the tumor showed encapsulation with smooth 
surface and firm consistency. There was an ingrowth in a dilated internal 
acoustic meatus and adhesions were found with the pons cerebri. It was not 
possible to remove the tumor totally. Postoperative there was a fast 
recovery, but a total facial paralysis House grade VI4 remained. The left ear 
was completely deaf. There were no vertigo problems afterwards. MRI-
scanning three years after the operation showed no growth of the remaining 
part of the tumor. 
Figure 1: 
MRI without Gadolinium of the rhabdomyoma in the left cerebello-pontine 
angle 
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Figure 2: 
CT-scan with contrast of the rhabdomyoma in the left cerebello-pontine angle 
Recently four years later a cross face nerve transplant was made using the 
left sural nerve to reinnervate the left facial nerve. 
PATHOLOGY 
During the operation a frozen section examination was performed and 
because of the presence of matured skeletal muscle a diagnosis of teratoma 
was suggested. In the permanent paraffin sections the tumor showed large 
well developed matured skeletal muscle fibers with easily indentifiable 
heamatoxylin and eosin stain cross striations, accentuated by PTAH-Mallory 
stain (figure 3). The fibres were arranged in irregular fascicles and separated 
by various amount of fibrocollagenous tissue. No cystic structures, vacuola-
ted cells or spider cells were found. There was no mitotic activity. Muscle 
fibres showed diffuse cytoplasmic immunoreactivity for desmin, muscle 
specific actin HHF-35 and myoglobin. 
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Figure 3: 
Photomicrograph of the tumor illustrating well developed skeletal muscle 
fibres with easily identified cross striation accentuated by PTAH-Mallory 
stain. The picture is consistent with rhabdomyoma (X 250). 
No glial tissue was detected and there was no reaction for S100 protein and 
GFAP. Some tumor cells stained also for vimentin. The diagnosis rhabdomy-
oma was rendered. 
DISCUSSION 
Hearing loss and even deafness of one ear in childhood is a regular finding 
in daily practice. Most of the time the hearing loss is due to middle ear 
problems and will be solved in time, sometimes using medication or middle 
ear ventilation tubes. When a sensorineural hearing loss is found there is a 
serious indication for further investigations. Tumors as in this young child 
are rare but can exist for several years giving symptoms which should not be 
overlooked. 
Chapter Vile 125 
Congenital intracranial tumors are rare and seldomly found in the cerebello-
pontine angle5. A rhabdomyoma is defined as a benign and usually circum-
scribed tumor consisting of mature muscle cells6. Other benign mesenchymal 
tumors with intracranial locations such as leiomyoma of fibrous xanthoma 
were also sporadically reported8. 
The location of rhabdomyoma can be cardiac or extracardiac. Cardiac 
rhabdomyomas are rare congenital tumors resulting from early dysembryoge-
netic disorder of organogenesis. They are generally benign lesions conside-
red as hamartomas which may be the first manifestation of Bourneville's 
tuberous sclerosis8. The extracardiac rhabdomyomas may assume a number 
of histologic patterns. Tumors composed of uniform large polygonal 
eosinofilie cells with occasionally cross striation are classified as the adult 
type. Those consisting of small mesenchymal cells and spindled skeletal 
muscle cells are classified as the fetal type. Both tend to occur in the head 
and neck region6·910·11. A third form, the genital type with cells bearing 
resemblance to both the adult and fetal type is most often seen as polypoid 
mass in the vagina and vulva12·13. Fetal extracardiac rhabdomyomas occur 
principally in infants and young children and have predilection for the 
postauricular region14 and are even rarer than the adult type rhabdomyo-
mas13. They show close resemblance to rhabdomyosarcomas. Of particular 
interest is their association with multiple basal cell carcinomas and anomalies 
of the rib and the iridocorneal angle of the eye13. In the adult form the tumor 
can be found multifocal in the head and neck region9·15. In the neck the adult 
type rhabdomyoma seems to arise from the branchial musculature of the 
third and fourth branchial arches. Therefore the tumor is found most 
frequent in the region of the larynx, pharynx, floor of the mouth and basis of 
the tongue13·16. Both the adult and fetal type rhabdomyomas are more 
common in males912. Recently a juvenile type of rhabdomyoma has been 
described as an intermediate form between the fetal and adult type17,18. 
Microscopically intracranial rhabdomyomas must be distinguished from 
rhabdomyosarcomas, medullomyoblastomas, malignant triton tumors and rare 
intracranial rhabdoid tumors7,19·20·21. Rhabdomyomas may be encountered as a 
component of the malignant germ cell tumors of the pineal gland and 
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suprasellarregion, particularly in immature teratomas. Skeletal muscle 
differentiation can als be rarely seen in glyosarcomas22, gliomas and 
meningiomas7,23. In our case the tumor that can be classified as the adult type 
rhabdomyoma showed other distinctive features and no mitotic activity. The 
immature neuroblasts, immature mesenchymal cells, vacuolated or globular 
rhabdomyoblasts and glial cells were not found. Our immuno-histochemical 
finding were consistent with the rhabdomyomatous phenotype9'24. 
The 4 year follow up time free of recurrent disease confirmed the benign 
character of the lesion. Overall incidence of rhabdomyomas is much lower 
than rhabdomyosarcomas both extracranial and intracranial3,7,13. Rhabdomyo-
sarcoma is a highly malignant tumor and patients stay alive no longer than 2 
years despite of agressive chemotherapy and radiotherapy25. 
It is a question of debate wether the presented case should be considered as a 
choristoma or a true neoplasm. We were able to find in bibliography only 
one other case of a primary intracranial rhabdomyoma which involved the 
trigeminal nerve. The authors regarded the lesion as choristoma and 
postulated that the tumor arose from embryologically disrupted and 
dislocated masticatory myogenic tissue following innervation of the 
mandibular motor division of the trigeminal nerve3. The foci of skeletal 
muscles can be found accidentally in normal meninges, but their relationship 
to rhabdomyomas and rhabdomyosarcomas is not clear7,26,27. Rhabdomyosar-
comas have been reported to arise in both the leptomeninges and the brain 
parenchyma23,25'28. Focal skeletal muscle ectopia in leptomeninges has been 
reported predominantly in children with other developmental anomalies of 
the central nerve system and sometimes chromosomal abnormalities which 
suggests faulty mesenchymal differentiation secondary to a genetic error in 
the tissue regulation. In several cases skeletal muscle has been found in 
leptomeninges of pontine region or ponto-medullary junction26'29. Interestin-
gly the tumor reported by us was also located in the pontine angle area. 
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CONCLUSION 
Unilateral sensorineural hearing loss may be an alarming symptom also in 
childhood. Nowadays having acces to CT-scanning and M RI further 
investigations should be considered to find the cause of the phenomenon. In 
childhood rare congenital tumors as a rhabdomyoma are sometimes found in 
these cases and an early exploration increases the chance of succesful radical 
surgery. The presented child is alive and well 4 years after operation, 
although only an incomplete resection could be performed. An additonal 
surgical procedure for the total facial paralysis had been done later. 
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Summary and conclusions 
Acoustic neuromas are intracranial benign tumors with changing patterns in 
diagnosis and therapy. This thesis presents the results of 13 years of acoustic 
neuroma surgery in the Nijmegen University Hospital in the Netherlands. 
Several aspects of the diagnosis and treatment are evaluated, as well as the 
patient's opinion after surgery. The general aim of these studies was to gain 
more insight into the natural history, growth rate and clinical behaviour of 
this tumor. Also the differences between the suboccipital and translabyrinthi-
ne-transotic approaches and tumor sizes were studied. The results of this 
thesis may be used to develop future strategies in acoustic neuroma 
dilemmas. In Chapter I a general introduction is given with a short historical 
review, and the aim and outline of the study are delineated. 
In chapter II correlations were examined between tumor size, patient age, 
signs and symptoms, and duration of symptoms. No support was found for 
any of the correlations mentioned in other studies and no relationships could 
be demonstrated between the parameters. Even using the present optimal 
diagnostic facilities it will be difficult to detect all acoustic neuromas in an 
early small stage. One of the reasons is that there is no clear defined 
stepwise increase of signs and symptoms with the growing tumor. All sizes 
of tumors can occur at any age, with a short or long history. Without the 
correlations suggested in earlier work the diagnostic strategies should be 
altered and only be based upon established facts. In the otological, vestibu-
lar, otoneurological and neurological diagnoses an acoustic neuroma should 
more often be considered in the differential diagnosis. In case of doubt more 
often a Gadolinium enhanced MRI scan has to be made. 
In chapter III the time to discover an acoustic neuroma is calculated. The 
title of the chapter mentiones the word delay rather than time, because it 
takes on average about 4 years for the diagnosis to be made. The time delay 
is due to the patient and the general practitioner as well as the specialist who 
should have the neuro-otological expertise. In 30 out of 164 patients the 
specialist needed more than 12 months, which often retrospectively could 
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have been avoided using the right diagnostic procedure. 
Circumstances like the relatively low prevalence of acoustic neuromas, 
possibly unclear symptoms, and other diseases present form an explanation 
for the delay. Interestingly the mean tumor size decreases every year, 
whereas the mean diagnostic delay does not. The increasing amount of early 
detected small tumors together with the constant number of large tumors may 
account for the decrease of the average tumor size. Since the delay time 
itself is several years, it will be hard to recognise a changing pattern of this 
time in the 13 year period of investigation. Also the availablity the MRI scan 
did not improve untili the end of the study period, and was even then still 
limited. 
Chapter IV presents the results of the translabyrinthine and transotic surgery. 
The shift in technique from the translabyrinthine to the modified transotic 
approach improved the results. There was a gradual decrease in facial nerve 
morbidity and surgical complications. The improved technique will be one 
factor, a second factor may be the learning curve of the surgeons: in other 
words, the increased experience with these transtemporal approaches also 
seemed to have affected the results. The outcome of surgery reported in this 
chapter match with the best series reported in the literature. 
In chapter V the results of the suboccipital approach are presented. The 
surgical complications and facial nerve grades are comparable to other 
centres who use the suboccipital and/or retrosigmoidal approach. Hearing 
preservation is only succesfull in a minority of these patients, but is an 
advance of this approach, like it is in the middle fossa approach1,2. Tumors 
of all sizes were operated. Unfortunately the facial nerve function after 
surgery is worse compared to other approaches used by major centres over 
the world. Despite the carenili removal of the tumor, accepting non-radical 
surgery, the results did not improve significantly. The risk of regrowth, and 
the increasing complication rate of surgery for residual tumor, is demonstra-
ted. Although in some selected cases non-radical surgery might still be 
indicated, in general there seems to be little or no credit anymore for 
subtotal removal. Strictly defined near total removal in acoustic neuroma 
surgery offers better prospects. 
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The quality of life after acoustic neuroma surgery is documented in chapter 
VI. The general state of health after surgery is of inferior quality compared 
to the non-operated population. The recuperation takes a long time and is not 
always complete. Effects on previous symptoms like vertigo, tinnitus, 
hearing loss and facial function are unpredictable. The surgery often has a 
negative influence on social life and work. Suboccipital surgery for equal 
tumor sizes results in more postoperative pain, more declarations of 
incapacity to work, poorer facial nerve function and more visits to the 
general practitioner. The translab/otic approach is associated with more 
intense pain, and more postoperative vertigo. The size of the tumor 
influences the capability to go to work again. The chance of regaining total 
work capacity decreases with increasing tumor size. Surprisingly the 
reoperated patients have a better state of general health and less pain. On 
average their facial function is worse than after only one operation. They 
also suffer more from emotional problems, but these facts did not seem to 
affect their opinion about their general health. The minor daily health 
problems may be cancelled out against the knowledge of having a serious 
reappearing brain tumor. 
The case report in chapter Vila on the unilateral growth of an acoustic 
neuroma showes a mean doubling time of the tumor of 15 months, and a 
length growth rate of 0.33 cm/year. Documented cases may contribute to 
more knowledge about tumor growth rate. Standardisation of tumor 
measuring methods are necessary. The best way of documenting the tumor 
growth is the calculation of the volume and the doubling time of the tumor. 
Not always is a bilateral tumor in the cerebello-pontine angle an acoustic 
neuroma as a result of Neurofibromatosis II. The case report in chapter Vllb 
states again that a diagnosis is only certain when confirmed by pathological 
examination. In the present "wait and see" policy this should be taken into 
account. The radiological confirmed acoustic neuroma may always be 
another histological entity3. 
The unilateral hearing loss of the child in chapter Vile is a common 
problem. The final diagnosis is unexpectedly a very rare tumor. With the 
noninvasive diagnostic techniques available nowadays more often an MRI or 
CT scan should be made. The chance of finding such a diagnosis is small, 
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but of great importance to the patient. 
CONCLUDING OBSERVATIONS 
The decade of the nineties should be considered a decade of reflection. New 
diagnostic procedures like MRI have made it possible to detect more tumors, 
in an early stage. 
The increasing number of small tumors being diagnosed raises new and other 
questions4·5·6. The radiological diagnosis of an acoustic neuroma, which 
causes hardly any impairment for the patient, may not always end in radical 
surgery anymore. Solving one problem gives rise to many others. Nowadays 
diagnostic facilities make it possible to determine all acoustic neuromas of 2 
mm and more. Unfortunately the reality is that nevertheless still large tumors 
are found, and the diagnostic time is many months. With the conclusions of 
chapter II it is explicable that not always the tumor will be recognised in an 
early stage. Nowadays more small tumors are detected, and that already is 
one important step forwards. A diagnostic time of one year should be 
considered in this decade as no delay according to Thomson et al7. In this 
view at least an attempt should be made to exclude the large delays that 
occur after incomplete examinations with rather clear symptoms. More often 
MRI will have to be performed. The decrease in costs of this technique 
makes it even more attractive for excluding retrocochlear diseases. The 
waiting list and time for MRI examinations of the cerebellopontine angle 
should be shortened by an increasing capacity for this indication of 
diagnosis. 
Advanced surgical methods are helpfull in removing the tumor with almost 
no additional damage. In the past the diagnosis was often only made in an 
almost inoperable stage, and any kind of life-lengthening procedure was 
welcome. At present the differences in results between surgical approaches 
become relatively small, and all methods will lead to acceptable but still 
different success rates. 
Not one of the surgical approaches for acoustic neuroma surgery is superior 
in all cases. The choice depends on many factors as stated before. With 
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regard to facial nerve function the results of the translab/otic approach for 
tumors till about 30 mm are superior to the general suboccipital and 
retrosigmoidal approaches. Possibly this may also be the case for larger 
tumors. The complication rate is comparable, but hearing preservation of the 
affected tumor side is impossible using transtemporal surgery. The patient's 
general opinion of the results is in favor of the translab/otic approach as 
much as the suboccipital approach. The middle fossa approach and combina-
tions of approaches, not studied in this thesis, also bare promising results. A 
carenili selection of the technique, taking all factors into account, will lead 
to the most desirable result. More centralisation of surgery for acoustic 
neuroma will offer the opportunity of the best approach in well trained hands 
for the individual patient. 
In this thesis deflection on the state of art have been presented. New 
developments are knocking on the door again and perhaps will influence an 
intervention in the next decade. Will it be the decade of the Gamma knife? 
The sparsely presented results are still questionable. Will it be the decade of 
the endoscopic brain surgery, or are the rapidly improving techniques of the 
cochlear and brainstem implants the answer to the hearing preservation 
problems in some patients with bilateral deafness. Further studies on the 
variability of tumor growth and the natural history will need attention. 
Quality of life after surgery may get the leading role in selecting the 
approach. Acoustic neuroma are what is called "benign" tumors, but the 
consequences for patients with this disease are still far beyond the meaning 
of benign. 
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Samenvatting en conclusies 
Acousticusneurinomen zijn goedaardige hersentumoren, waarbij in de 
diagnose en therapie een veranderend patroon is te herkennen. Dit proef-
schrift laat de resultaten zien van 13 jaar diagnostiek en chirurgie van 
acousticusneurinomen in het Nijmeegse universiteitsziekenhuis St. Radboud. 
Verschillende medische aspecten van diagnostiek en therapie worden belicht, 
waarbij ook de mening van de patiënt over de kwaliteit van leven na de 
operatie is onderzocht. Het doel van het proefschrift is onder andere meer 
inzicht te krijgen in de symptomen, het ziekteverloop en de groeisnelheid 
van deze tumoren. Twee verschillende manieren van opereren worden met 
elkaar vergeleken, waarbij ook de grootte van de tumor is betrokken. De 
resultaten van het proefschrift kunnen leiden tot betere onderzoeks- en 
behandelingsprotocollen bij acousticusneurinomen. Hoofdstuk I start met een 
historisch overzicht. 
In hoofdstuk II is onderzocht of er correlaties zijn tussen de grootte van de 
tumor, de leeftijd van de patiënt, symptomen van de tumor, en de duur van 
de klachten. Eerder in de literatuur genoemde correlaties worden in dit 
onderzoek niet bevestigd. Er wordt geen enkel verband gevonden tussen 
bovengenoemde parameters. Het is daarom moeilijk om een tumor altijd in 
een vroeg stadium te ontdekken. De symptomen treden vrij willekeurig op, 
en zijn niet altijd afhankelijk van de grootte van de tumor. Ook de duur van 
de symptomen is geen maat voor de grootte van de tumor. Omdat er geen 
correlaties zijn tussen de verschillende parameters is het zinvol diagnostische 
beslissingen alleen te laten afhangen van feiten, en niet van veronderstellin-
gen. Bij het stellen van diagnoses in de otologie, otoneurologie, neurologie 
en de vestibulologie zou vaker moeten worden gedacht aan een acousti-
cusneurinoom. In gevallen van twijfel kan een MRI-scan met Gadolinium 
worden gemaakt. 
De tijd die nodig is om de diagnose acousticusneurinoom te stellen komt in 
hoofdstuk III naar voren. In de titel wordt benadrukt dat de vaststelling van 
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de ziekte gemiddeld bijna 4 jaar duurt. De lange duur voordat de diagnose 
gesteld is wordt zowel door de patiënt samen met de huisarts als door de 
medische specialist veroorzaakt. De specialist heeft bij 30 van de 164 
patiënten een periode van meer dan een jaar nodig om tot de diagnose te 
komen. Terugkijkend naar de gegevens had deze periode misschien korter 
kunnen zijn. Een verklaring voor de lange duur kan liggen in de zeldzaam-
heid van deze tumor, de onduidelijke symptomen, of andere ziekten die 
tegelijkertijd optreden met vergelijkbare symptomen. Opvallend is dat de 
gemiddelde grootte van de tumoren per jaar wel minder wordt, maar dat de 
tijd voor de diagnose niet afneemt. Mogelijk worden er nu meer kleine 
tumoren ontdekt, bij hetzelfde aantal grotere. Misschien is de onderzoekspe-
riode van 13 jaar ook te kort om een verandering te ontdekken in de 
diagnoseduur, welke zelf gemiddeld 4 jaar is. Nieuwe onderzoeksmethoden 
zoals de MRI-scan kunnen hierop ook invloed gaan hebben, maar deze 
techniek was in de onderzoeksperiode alleen de laatste jaren, en toen nog 
slechts spaarzaam beschikbaar. 
Hoofdstuk IV gaat over de resultaten van de translabyrinthaire en transoti-
sche chirurgie. Aanvankelijk werd de translabyrinthaire operatieweg 
gebruikt, maar geleidelijk is deze vervangen door de gemodificeerd transoti-
sche techniek, waarbij ondermeer de uitwendige gehoorgang wordt afgeslo-
ten, en soms het slakkenhuis wordt weggeboord. De resultaten worden in de 
tijd steeds beter, met minder complicaties en een steeds betere functie van de 
gelaatszenuw na de operatie. De oorzaken hiervoor kunnen mogelijk worden 
gezocht in de verbeterde techniek, en in de toegenomen ervaring van de 
operateurs. 
Resultaten van de suboccipitale (retrosigmoidale) chirurgie worden in 
hoofdstuk V besproken. Het aantal complicaties, en de functie van de 
gelaatszenuw na chirurgie is gelijk aan andere klinieken, welke ook via deze 
operatieroute werken. Het gehoor is in een klein aantal patiënten gespaard, 
wat een voordeel is van deze techniek. Tumoren van alle groottes werden 
geopereerd. De resultaten van de gelaatszenuw na chirurgie zijn echter beter 
als via een andere operatieweg de tumor wordt verwijderd, wat blijkt uit een 
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literatuuroverzicht. In deze serie is geprobeerd de schade van de ingreep te 
beperken door niet altijd de gehele tumor te verwijderen. Dit had geen 
duidelijk effect op de resultaten. Wel blijkt een aantal incompleet verwijder-
de tumoren weer te gaan groeien, en bij heroperaties neemt het aantal 
complicaties toe, en de functie van de gelaatszenuw af. Dit geeft aan dat 
alleen in uitzonderingsgevallen de tumor gedeeltelijk verwijderd kan worden. 
Chirurgie waarbij alleen zeer kleine resten aanwezig blijven geeft betere 
perspectieven, terwijl steeds gestreefd moet worden naar volledige verwijde-
ring. 
De kwaliteit van het leven na chirurgie wegens een acousticusneurinoom is 
beschreven in hoofdstuk VI. De algemene gezondheid van geopereerde 
patiënten is minder dan die van een vergelijkbare groep. De periode van 
herstel is lang, en het herstel is niet altijd volledig. De effecten op sympto-
men van voor de operatie, zoals oorsuizen, duizeligheid, gehoorsverlies en 
de functie van de gelaatszenuw, zijn onvoorspelbaar. De operatie heeft een 
negatieve invloed op het sociale leven en werk. Na een suboccipitale operatie 
bestaat vaker pijn, meer arbeidsongeschiktheid, een minder goede functie van 
de gelaatszenuw, en werd de huisarts vaker dan gemiddeld bezocht. Na de 
translabyrinthaire/transotische operaties is de pijn minder frequent maar wel 
heviger, en na de operatie bestaat er meer duizeligheid. Bij een grotere 
tumor is er meer kans op arbeidsongeschiktheid. Opvallend is dat de 
patiënten met heroperaties zich beter voelen en minder pijn hebben dan de 
eenmaal geopereerde patiënten, terwijl de gelaatszenuw minder goed werkt, 
en er meer emotionele problemen zijn. Mogelijk zijn patiënten na heropera-
ties zich meer bewust van het bedreigende ziektebeeld van een opnieuw 
groeiende hersentumor, waardoor andere klachten minder belangrijk lijken. 
In hoofdstuk Vila wordt een patiënt beschreven, waarbij het mogelijk was de 
mate van groei van een acousticusneurinoom te bepalen. De tumor verdub-
belde zich in 15 maanden, en groeide 0.33 cm per jaar in doorsnede. Door 
patientengeschiedenissen wordt het mogelijk steeds meer te leren over de 
groeisnelheid van tumoren. De tumorgrootte dient wel steeds op dezelfde 
wijze gemeten te worden, en het nemen van de volume-maat is hierbij het 
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meest nauwkeurig. Ook de verdubbelingstijd van de tumor kan genomen 
worden. 
Meestal is een dubbelzijdige tumor in de brughoek het gevolg van Neurofi-
bromatose type II, waarbij in het zenuwstelsel op verschillende plaatsen 
neurinomen worden gevormd. De tweede patientengeschiedenis Vllb laat 
zien dat er ook andere dubbelzijdig voorkomende tumoren zijn. Alleen 
microscopisch weefselonderzoek door de patholoog geeft zekerheid. Dit is 
van belang voor patiënten waarbij een tumor wordt gezien op de röntgenfoto, 
en een afwachtend beleid wordt gevolgd. 
Eenzijdig gehoorsverlies bij kinderen komt veel voor. In hoofdstuk Vile 
wordt een patiënt gedemonstreerd waarbij de oorzaak hiervan een zeldzame 
brughoektumor is. Met de beschikking over moderne onderzoeksmethoden 
als CT en MRI, welke weinig belastend zijn voor patiënten, wordt het 
mogelijk een dergelijke diagnose op tijd te stellen. Aanbevolen wordt om 
vaker deze diagnostiek toe te passen. 
In de jaren negentig is het mogelijk geworden om acousticusneurinomen in 
een vroeg stadium, met nog een kleine omvang, te ontdekken. Dit stemt tot 
nadenken. Het vinden van veel kleine tumoren roept nieuwe vragen op. Niet 
alle patiënten met een nog kleine tumor moeten direct geopereerd worden, 
zolang niet vast staat dat het proces groeit. De diagnostiek is verbeterd, maar 
wat de beste behandeling is, is nog niet bekend. Het is overigens niet zo dat 
tegenwoordig alle tumoren in een vroeg stadium worden gevonden. 
Hoofdstuk III maakt duidelijk waarom acousticusneurinomen soms moeilijk 
te diagnostiseren zijn, en waar de tijdsintervallen ontstaan. Een jaar lijkt 
voor de diagnostiek nog een acceptabele tijd te zijn. Toch moet het mogelijk 
zijn om eerder tumoren te ontdekken als steeds tijdig een volledig onderzoek 
wordt gedaan, met ook een MRI-scan. De kosten van dit onderzoek nemen 
de laatste jaren geleidelijk af. De capaciteit voor dit onderzoek moet 
toereikend zijn of worden voor de toenemende vraag. 
Aanvankelijk werden tumoren steeds in een laat en inoperabel stadium 
ontdekt, en werd alleen geprobeerd het leven nog te verlengen. De heden-
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daagse chirurgie kan bij kleine tumoren het acousticusneurinoom verwijderen 
zonder veel schade aan te richten. De resultaten van de huidige technieken 
ontlopen elkaar nog steeds. Er is nog geen ideale operatieweg. De keuze van 
techniek hangt af van veel factoren. Als bijvoorbeeld alleen naar de 
aangezichtszenuw wordt gekeken lijkt de keuze voor kleinere tumoren tot 
30mm uit te gaan naar de translabyrinthaire/transotische operatie, maar het 
gehoor gaat hierbij altijd eenzijdig verloren. De patientenenquete laat ook 
geen eenduidig oordeel over de operatieresultaten zien. Andere operatiewe-
gen dan in dit proefschrift beschreven zijn, zoals de middle fossa approach 
of combinaties van verschillende operaties laten goede resultaten zien. Er 
dient steeds een goede afweging gemaakt te worden. De beste mogelijkheid 
hiervoor wordt geboden in gespecialiseerde centra. 
In dit proefschrift zijn recente resultaten van de behandeling van acousti-
cusneurinomen beschreven. De ontwikkeling gaat echter snel. Misschien is 
toch het zogenaamde Gamma-knive, behandeling middels gebundelde 
radiotherapie, een goede techniek. Resultaten moeten dit nog uitwijzen. De 
operaties met sterk verbeterde kijkinstrumenten worden geleidelijk steeds 
meer toegepast. Ook de resultaten van cochleaire implantaten, en hersen-
stamimplantaten, zijn hoopgevend om het gehoor te behouden, zeker bij 
dubbelzijdige tumoren. Met name studies over de groeisnelheid en het 
natuurlijk beloop van acousticusneurinomen blijven van groot belang. Ook de 
quality of life van patiënten na de operatie gaat steeds meer tellen. Hoewel 
acousticusneurinomen goedaardige tumoren zijn hebben ze grote gevolgen 
voor een patiënt met deze aandoening. 
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STELLINGEN 
behorende bij het proefschrift 
"Acoustic Neuromas" 
van 
JOS VAN LEEUWEN 
Stellingen: 
1. De translabyrinthaire en de gemodificeerd transotische operatie-
routes zijn voor acousticusneurinomen tot 3 cm en mogelijk 
ook de grotere een optimale behandelingsmethode, en verdienen 
de voorkeur als het gehoor geen doorslaggevende rol speelt, 
(dit proefschrift). 
2. Bij de weergave van resultaten van chirurgie wegens acousti-
cusneurinomen zou de grootte van de tumor in volume-maten 
moeten worden weergegeven, om een juiste vergelijking tussen 
de verschillende centra mogelijk te maken, (dit proefschrift) 
3. Ook na een succesvolle operatie vanwege een acousticusneuri-
noom is een vermindering van de quality of life te verwachten, 
en patiënten dienen ook hierover voorgelicht te worden, (dit 
proefschrift) 
4. Voor de subtotale verwijdering van acousticusneurinomen is 
nog slechts in uitzonderingsgevallen een indicatie, (dit proef-
schrift) 
5. De tijdsduur van een jaar is voor het stellen van de diagnose 
"acousticusneurinoom" in de tweede lijn vooralsnog een accep-
tabele periode. 
6. Om een acousticusneurinoom met voldoende zekerheid uit te 
sluiten dient bij een onverklaard asymmetrisch perceptief 
gehoorsverlies van meer dan 20 dB voor tenminste twee fre-
quenties in het audiogram steeds een MRI met Gadolinium 
gemaakt te worden. 
7. Acousticusneurinomen zijn gezwellen die onbehandeld vaak tot 
de dood zullen leiden. Zij dienen daarom niet alleen ingedeeld 
te worden onder de neuro-otologie, maar ook onder de oncolo-
gie, in het bijzonder de neuro-otologische oncologie. 
8. De klinische beschrijving van het Usher syndroom type II, dat 
leidt tot doof-blindheid, moet herzien worden, omdat het 
perceptieve gehoorsverlies bij het Usher syndroom type II A 
wel progressief kan zijn. (Van Aarem et al, Ann Otol Rhinol 
Laryngol 1995, in press) 
9. Voor patiënten met een eenzijdig gehoorsverlies, bijvoorbeeld 
na een translabyrinthaire of gemodificeerd transotische benade-
ring wegens een acousticusneurinoom, is een aanpassing met 
een Bone Anchored Hearing Aid op het aangedane oor zinvol 
en cosmetisch aantrekkelijk. 
10. Het feit dat oto-acoustische emissies pas ruim 30 jaar nadat hun 
bestaan voorspeld was "ontdekt" werden, toont aan dat consen-
sus in de wetenschap gevaarlijke kanten heeft. 
11. De huidige financiering van kankeronderzoek leidt tot onnodige 
verspilling van schaarse middelen, en dwingt veel onderzoekers 
tot een carrière buiten de universitaire wereld. 
12. Een sportieve auto bestaat niet. 



